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ABSTRACT
The lateral line is a mechanosensory system used by fish to sense the movement of water.
It is evolutionarily related to the inner-ear in humans. For both organisms, the binding of the
CXCL12 (SDF-1 ligand) to the CXCR4 receptor induces conformational changes needed to
activate signal transduction. This signaling results in numerous cellular responses such as cell
fate, chemotaxis, and gene transcription. Interestingly, researchers have found that another
signaling molecule, CXCL14, can also bind to the CXCR4 receptor with high affinity
(Tanegashima et al., 2013). As a result, we hypothesize that CXCL14 modulates CXCL12mediated chemotaxis, presumably acting as an allosteric regulator.
We are concerned with the allosteric relationship between CXCL14 and CXCL12 and
how those relationships affect gene expression in lateral line development. In order to study this
interaction, zebrafish were used as our model organism. To examine the effects of CXCL14 on
CXCL12-mediated gene transcription, zebrafish embryos were microinjected with CXCL14
antisense morpholino and incubated for a period of three timepoints: 24 dpf, 36 dpf, and 48 dpf,
when lateral line development occurs. Our preliminary results suggest that the absence of
CXCL14 affects the gene expression of CXCL14, CXCL12, CXCR4, CXCR7, epcam, claudin,
and snail1b during lateral line development, thereby suggesting the allosteric capabilities of
CXCL14. Further studies will be conducted to determine the degree to which CXCL14 affects
the transcription levels of these genes.
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INTRODUCTION
Zebrafish, or Danio rerio, are freshwater fish native to the Himalayan region. In order to
properly detect and avoid predators, zebrafish rely on a lateral line system to sense movement in
the water. The lateral line system is a mechanosensory system used by fish to detect water
current stimuli. Similar to the inner-ear in humans, the lateral line system allows zebrafish the
ability to “hear” their surroundings. This provides zebrafish with coordination and balance. For
zebrafish, lateral line development is dependent on activation of the CXCL12 (SDF-1 ligand)CXCR4 signaling pathway. Once activated, this signaling pathway results in numerous cellular
responses such as chemotaxis, changes in metabolism, and/or changes in gene expression. In
recent years, however, CXCL14 has been shown to potentially modulate the CXCL12-CXCR4
pathway (Tanegashima et al., 2013). In our lab, we are concerned with the extent to which
CXCL14-mediated gene expression affects lateral line development.

Part 1- Genetic information and signaling pathways
1.1. The central dogma and gene expression
To begin, every form of life is bound together by a shared characteristic: genetic
information. On a molecular level, the flow of genetic information from one macromolecule to
another is known as the “Central Dogma of Molecular Biology” (Figure 1) (Crick, 1970). This
process begins with the interactions between deoxyribonucleic acid (DNA) and ribonucleic acid
(RNA). These nucleic acids store and transfer the information needed to provide the cell with
instructions for making proteins (Lodish et al., 2000). Proteins are important macromolecules
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that are essential for all life. For example, proteins provide structural support in the form of
muscles as well as immunological support with the production of antibodies.

Figure 1. The central dogma model for molecular biology. Solid arrows denote general transfers
of genetic material whereas dotted arrows show special transfer of genetic material. Adapted from
Francis Crick (1970).

The genetic material stored in DNA is composed of four chemical bases: adenine (A),
guanine (G), cytosine (C), and thymine (T) (Ptashne, 2004). Similar to letters forming words and
sentences, these nucleotides serve as building blocks for the formation of nucleic acid polymers
such as DNA or RNA (Ptashne, 2004). Likewise, the order in which these nucleotides are
arranged determines the genetic information they convey. This process resembles how an
arrangement of words changes the meanings they convey.
Embedded within DNA are genes which contain the nucleotide sequences needed to code
for molecules. Some genes code for proteins with specialized functions such as transcription
factors. When transcription factors bind to DNA, they can either activate or repress gene
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transcription (Brooker et al., 2014). When the cell receives signals to produce proteins, the
corresponding genes that code for them are activated. RNA polymerase transcribes genes into
multiple copies of messenger RNA (mRNA) and, from there, ribosomes can now translate these
mRNAs into the proteins needed for the cell (Ptashne, 2004). Once these proteins are
synthesized, they can now carry out specialized jobs such as receiving and transmitting signals
involved in regulating gene expression.

1.2. Signal transduction pathways and gene expression
The cellular mechanisms that govern gene transcription are composed of several parts
that come together to form signal transduction pathways. The start of signaling pathways begins
with the interactions between a signaling molecule, known as a ligand, and its corresponding
receiving molecule or, receptor (Brooker et al., 2014). Ligands are extracellular signaling
molecules with a high affinity for their receptors; meaning they can recognize and bind to one or
at most a few target receptors (Alberts et al., 2002). These target receptors are found on the
surface of cells. When ligands bind to their respective receptors, communication occurs where
extracellular signals are transduced to the molecules that govern intracellular responses (Figure
2).
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Figure 2. General schematic of the CXCL12-CXCR4 cell signaling pathway. When
chemokine ligand 12 (CXCL12) binds to its corresponding chemokine receptor (CXCR4), a signal
transduction pathway is activated. This leads to a series of cellular responses such as changes in
gene expression. Gene transcription can either be upregulated or downregulated, causing an
increase or decrease in gene expression respectively. When chemokine ligand 14 (CXCL14) binds
to the same receptor, CXCL12-mediated signaling is inhibited.

In order to produce a cellular response, there must be an interaction between ligands and
receptors. Namely, when ligands bind to their receptor, a conformational change must occur
wherein the shape or activity of the receptor is changed (Brooker et al., 2014). These
conformational changes activate the ligand-receptor complex and allow extracellular cues from
the ligand to be translated into signals that can be fed into the appropriate signal transduction
pathway (Brooker et al., 2014). Once these signals are transmitted inside the cell, molecules
4

within the signaling pathway are activated. Thereafter, the signal grows stronger until a cellular
response in produced.
Signaling pathways are composed of several molecules responsible for activating or
repressing a series of cellular responses (Brooker et al., 2014). As mentioned, the cell must
receive word of external stimuli through ligand-receptor binding. In response to extracellular
stimuli, factors that regulate cellular responses are activated (Gomperts et al., 2002). More
specifically, when the cell receives external cues, signals propagate to proteins residing in the
appropriate signal transduction pathway(s). These proteins undergo a series of changes in order
to send and amplify the signal. This is referred to as a signaling cascade (Brooker et al., 2014).
From one factor to the next, the signal cascades down a signaling pathway where it becomes
amplified. As more and more proteins are activated, the signal becomes stronger. Once these
signaling cascades take root, the signal continues to travel down a pathway until the appropriate
cellular response is produced. In my lab, we are focused on one very important cellular responsegene transcription.
Signaling pathways give rise to a wide variety of responses that regulate important
cellular functions such as gene transcription or cell differentiation, wherein the cell can
differentiate to fit the needs of the organism (Berg et al., 2002). When signaling pathways occur,
proteins that regulate gene transcription, also known as transcription factors, are activated
(Brooker et al., 2014). These transcription factors ultimately determine whether certain genes are
turned on or off. Biochemically speaking, gene expression is regulated by signal transduction
pathways and the proteins that either activate or repress them.
It is important to note that these pathways can affect gene expression in one of two ways:
during development and/or cell differentiation. As an organism develops, certain genes are
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turned on or off. This allow cells to differentiate into what the organism needs (Brooker et al.,
2014). From there, an embryo can develop properly without having too much or too little of a
certain product. Although regulation is a key function of cells, there will always be exceptions;
namely, cancer. In terms of malignant growth, cancerous cells multiply under conditions their
normal counterparts do not. This process is caused in part by certain genes being turned on or off
when they should not be (Ptashne, 2004).

1.3. Cancer biology
Since the first documented case around 1600 B.C.E., cancer has become a popular area of
study for human health (Sudhakar, 2009). In recent years, scientific research has expanded the
area of oncology, the study of cancer, to include more research for drug therapies that can target
and combat cancer. More often than not, cancerous cells take advantage of damaged DNA in
normal cells to utilize cell machinery for their own device (Sudhakar, 2009). While some cancer
cells continue to grow and develop without regulation, others take advantage of the circulatory
system and travel through the bloodstream (Brooker et al., 2014). When this occurs, cancer cells
circulating in the blood can come into contact with, and spread to, other parts of the body. This is
referred to as metastasis (Brooker et al., 2014). Through the circulatory system, cancer can
spread and grow in areas apart from the site of origin. One way the body defends against these
cells is through immunosurveillance.
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1.4. CXCL12 and CXCL14 are closely related CXC-family chemokines
Immunosurveillance is predominantly regulated by a family of chemokines (CXC).
Chemokines are small proteins that heavily regulate cell migration for both organogenesis (the
formation of organs) and immunosurveillance (Bacon et al., 2000). In particular, these CXCchemokines are chemotactic, meaning they cause cells to respond to chemical stimuli in their
environment. In doing so, chemokines promote cell migration for processes such as
organogenesis and immunosurveillance to occur (Collins et al., 2017).
Most notable among this family are chemokine-ligand 12 (CXCL12) and chemokineligand 14 (CXCL14), both of which are considered primordial chemokines due to their
evolutionarily conserved nature. Found among many different organisms, such as humans and
zebrafish, these ligands play an important role in embryogenesis (the formation and development
of an embryo) and immunosurveillance (Hara et al., 2012; Collins et al., 2017). As a result,
zebrafish are an important model organism for analyzing signal transduction pathways and
assessing their role in different cellular responses; many of which, are found in humans.

1.5. CXCL12-mediated signaling pathways
As mentioned previously, in order to promote cellular responses for processes such as
embryogenesis, a signaling cascade must occur. There are two known receptors for CXCL12:
chemokine-receptor 4 (CXCR4) and chemokine-receptor 7 (CXCR7) (Tanegashima et al.,
2013a). When CXCL12 binds to either CXCR7, or more importantly to CXCR4, a signaling
cascade is activated within the cell. As a result, a cellular response is produced that triggers
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important processes such as the homing of lymphocytes or the migration of primordial germ cells
and neural progenitors (Tanegashima et al., 2013a; Eckert et al., 2018).
Lymphocytes, also known as B cells or T cells, are a type of white blood cell responsible
for specific immunity (Brooker et al., 2014). Lymphocytes send signals to cells in response to
damage or infection, thereby playing a crucial part in regulating our immune system (Brooker et
al., 2014). Migration of cells is also observed during embryonic development. During
embryogenesis, cells migrate to where they are needed (Brooker et al., 2014). This allows for the
organism to develop properly for maturation. In addition, neural progenitors can migrate and
develop into neuronal cells and glial cells. These cells help maintain homeostasis and provide
support and protection for neurons (Eckert et al., 2018).
Unfortunately, if cells experience any form of damage, they are vulnerable to
opportunistic pathogens, programmed cell death (apoptosis), or cancer. During DNA
repair/DNA-damage pathways, cancer progression can occur. This is due to high levels of
genomic instability and an increase in mutation rate (Turgeon et al., 2018). In addition to DNArepair pathways, it is known that other signaling pathways play a role in cancer proliferation. In
particular, the CXCL12–CXCR4 signaling pathway has been shown to promote cancer growth
and metastasis (Tanegashima et al., 2013a; Tanegashima et al., 2013b; Eckert et al., 2018).
In recent years, researchers have discovered that the CXCL12–CXCR4 signaling
pathway is manipulated by several cancer types to promote cell growth and metastasis
(Tanegashima et al., 2013a). As a result, elevated levels of CXCR4 and CXCL12 have led to a
poor prognosis for cancer patients (Tanegashima et al., 2013b; Eckert et al., 2018). With elevated
levels, there is increased CXCL12-CXCR4 signaling, which has been shown to contribute to
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malignant tumor growth, metastasis, neoplastic transformation, and infiltration (Eckert et al.,
2018).
The CXCL12–CXCR4 signaling pathway has been attributed to the close relationship
between malignant growth in over 20 different cancers, including: lung, breast, and ovarian
cancers (Tanegashima et al., 2013b). Researchers have studied the CXCL12-CXCR4 pathway in
hopes of unlocking ways to combat and repress cancer growth. Consequently, in the process of
analyzing CXCL12-CXCR4 signaling, it appears another chemokine-ligand may hold the answer
to suppressing tumor growth.
Generally, it is understood that CXCL12 binds to CXCR4 to promote cell migration and
cell differentiation. Although these processes aid in organismal development, the CXCL12CXCR4 pathway can be used by opportunistic cancers to develop without any form of
regulation. In more recent years, however, it has been discovered that chemokine-ligand 14
(CXCL14) plays a very important regulatory role in the CXCL12-CXCR4 pathway.

1.6. CXCL14 as an allosteric modulator
In the field of cell biology, it is commonly accepted that ligands are matched to their
respective receptors. Allosteric regulators are molecules which influence (or modulate) the
signaling capabilities of ligands. More specifically, allosteric regulators can have an impact on a
ligand’s ability to activate or repress a target protein’s function (Rothman et al., 2015). In the
case of CXCL14, this chemokine may act as an allosteric modulator.
Similar to its counterpart (CXCL12), CXCL14 is a primordial chemokine. While
CXCL14 is an evolutionarily conserved chemokine, there does not appear to be a specific
receptor it binds to. Although a unique receptor for CXCL14 has not been identified, the ligand
9

is known to regulate a variety of normal cellular responses (Collins et al., 2017). For example,
CXCL14 has been shown to regulate metabolism, cell migration, and immunosurveillance.
In terms of cancer, CXCL14 has been shown to have both tumor-suppressing or tumorsupporting functions (Otte et al., 2014). CXCL14 expression varies among different cancer
types. As a result, CXCL14’s role in tumor suppression, and progression, differs (Collins et al.,
2017). For some cancers, CXCL14 gene expression is downregulated (Hara et al., 2012). This
contrasts with high levels of CXCL12 gene expression in many cancers. One possible
explanation for decreased CXCL14 expression in some cancers is that loss in CXCL14 results in
a loss of immunosurveillance of cancer cells. Therefore, a decrease in CXCL14 expression
promotes cancer cell survival and proliferation.
While a unique receptor for CXCL14 has not been identified, it has been shown that
CXCL14 can bind to CXCR4, the CXCL12 receptor, with high affinity (Hara et al., 2012;
Tanegashima et al., 2013a; Tanegashima et al., 2013b; Collins et al., 2017). In doing so,
CXCL14 interferes with CXCL12 signaling through its receptor. More specifically, CXCL14
inhibits CXCL12’s ability to initiate cell migration of bone marrow derived hematopoietic
progenitors (Tanegashima et al., 2013a; Tanegashima et al., 2013b). Hematopoietic progenitor
cells give rise to blood cells, B-cells, and T-cells. Whereas B-cells and T-cells aid in
immunological responses, blood cells can be divided into two primary groups. When red blood
cells are made, they exclusively transport oxygen to different parts of the body. On the contrary,
white blood cells can differentiate into numerous types of immune cells to target pathogens.
When the bone marrow is damaged, abnormal leukocytes can enter the lymphatic system
and use it to divide. In this situation, cancer cells can repurpose the CXCL12-CXCR4 signaling
pathway to promote tumor growth and metastasis (Tanegashima et al., 2013a). By using the
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CXCL12-CXCR4 pathway, cancer cells can continue to grow and divide without interruption. In
addition, their survival is facilitated by CXCL12’s ability to promote metastasis and cell
migration.
Several studies have demonstrated CXCL14’s ability to inhibit CXCL12-mediated
processes by binding to CXCR4. As a result, researchers have proposed that CXCL14 is a
natural inhibitor of CXCL12 by highlighting its ability to “fine-tune” the CXCL12-CXCR4
pathway (Tanegashima et al., 2013a). Due to the conservation of CXCL12 and CXCL14
sequences across organisms, it can be assumed that these two chemokine-ligands have evolved
together to assume regulatory functions within similar pathways (Tanegashima et al., 2013a). As
a result, we can assume that CXCL14 possesses the ability to allosterically modulate the
CXCL12-CXCR4 signaling pathway.
CXCR4, being a receptor, is found on the surface of cells; a location which facilitates
contact with external signals. CXCR4 contains transmembrane helices which allow extracellular
cues to communicate with signaling molecules inside the cell. On a chemical basis, CXCL12
contains an N-terminal region with the ability to bind to the transmembrane helices of CXCR4
(Tanegashima et al., 2013b). When this chemical interaction occurs, the CXCL12-CXCR4
signaling pathway is activated. Similarly, a specific domain within CXCL14 can bind to CXCR4.
In doing so, CXCL14 modulates CXCL12-CXCR4 signaling (Figures 2 and 3).
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Figure 3. Model explaining how CXCL14 can synergize with CXCL12 in the induction of
CXCR4-mediated chemokine responses. Conformational states can be influenced by ligand
binding (shown by the shift from black to yellow conformation upon CXCL14 binding).
CXCL14 binding induces allosteric changes in partner molecules that are present in CXCR4
dimers, thereby lowering the threshold of receptor activation by the functional ligand CXCL12
(shown here by the shift from black to blue conformations in the partner molecule). Adapted
from Collins et al. 2017.

The plasma membrane is a physical barrier which envelopes the cell and separates the
intracellular environment from its extracellular surroundings (Brooker et al., 2014). When the Nterminal region of CXCL12 comes into contact with CXCR4, a conformational change occurs
where molecules on the intracellular side of the plasma membrane receive signals from
extracellular stimuli. From there, signal transduction pathways are activated, and cellular
responses occur. Without this interaction, conformational changes do not occur, and signal
transduction is not activated. This process occurs in the presence of CXCL14.
CXCL14 has the ability to inhibit CXCL12-CXCR4 mediated activity in humans. When
approaching this from a pharmacological perspective, CXCL14 can potentially be used as a form
of drug therapy to combat CXCL12-mediated cancer growth. Due to its allosteric nature,
12

CXCL14 can be designed to out-compete CXCL12. In doing so, CXCL14 can be more apt to
bind to CXCR4, and with higher affinity. By preventing elevated levels of CXCL12 from
circulating and encountering CXCR4, CXCL14 can be designed to efficiently inhibit CXCL12mediated chemotaxis, thereby reducing cancer growth.
Many issues arise when undertaking a project of this caliber. Namely, without an
identifiable receptor, potential CXCL14-stimulated signaling pathways are not fully understood.
In order to design an effective form of drug therapy, we need to be aware of any competing
reactions that could potentially interfere with CXCR4-CXCL14 binding. As a means of
obtaining a better grasp of CXCL14 function, we must turn to model organisms for help.

Part II- Zebrafish and the lateral line system
1.1. Zebrafish as a model organism
Model organisms are widely studied species that are used to enhance our understanding
of human health. These model organisms are used for research due to their reproductive nature,
ability to maintain in a laboratory setting, and their value in experimental design (NIGMS,
2018). From mice, to worms, to fruit flies, the use of model organisms has led to extensive
research in the field of biology. It wasn’t until George Streisinger, however, that zebrafish were
brought into the spotlight (Parichy, 2015). Later dubbed the “founder of modern zebrafish
research,” Streisinger published a series of papers where he used zebrafish as a model organism
to investigate biology relevant to human health.
Zebrafish, or Danio rerio, are small freshwater fish native to the Himalayan region. Since
their debut in the 1980’s, zebrafish have emerged from the water as a novel model organism
13

(Parichy, 2015). Zebrafish are ideal model organisms for several reasons. They are small and
easy to maintain. They have external fertilization and can produce hundreds of embryos per
mating. Zebrafish embryos undergo rapid, external development and are transparent through
early development (Adams et al., 2018). This allows researchers a convenient way to visually
analyze the process of embryogenesis (Hsieh et al., 2002). As a result, zebrafish are used in
research to study development, disease, and physiology.
Following their increase in popularity, extensive work has been done on zebrafish,
including sequencing of their genome. Through genome sequencing, it has been revealed that
zebrafish contain roughly 70% of the same genes as humans (Wellcome Genome, 2014).
Moreover, many of these genes are associated with disease in humans. Researchers can use
molecular tools, such as morpholinos, to silence specific genes and analyze their function in
zebrafish in order to assess their role in humans (Adams et al., 2018). Morpholinos are a type of
stable antisense molecules that will complement mRNA molecules and prevent translation of a
functional protein product. This project utilized a morpholino targeted to CXCL14 and focused
on the effects of loss of CXCL14 function on the CXCL12-CXCR4 signaling pathway. More
specifically, its role in gene expression and embryonic development of the lateral line system.

1.2. The lateral line system
The lateral line system is a mechanosensory structure found in fish and is evolutionarily
related to the inner ear in humans. The lateral line system is a sensory network used by fish to
detect movements of water (Coombs et al., 2016). However, in order to sense water current
stimuli, zebrafish depend on neuromasts present in the lateral line (Chitnis et al., 2012).
Neuromasts consist of mechano-sensory hair cells that are innervated by sensory neurons
14

branching to and from the brain (Ghysen et al., 2004). For zebrafish to respond to their
environment, the brain needs to receive the stimulus associated with movement. Hair cells help
facilitate this communication.
Hair cells are so-called because they extend hair like ciliary bundles embedded within a
gelatinous cupula that is in contact with the water (Figure 4). Therefore, each neuromast has a
cupula which bends with movement of the water (Chitnis et al., 2012). Due to its gelatinous
nature, any movement in the water causes the cupula to bend in the direction of the stimuli
(Ghysen et al., 2007). As a result, the ciliary bundles also move. This collection of movement, in
both the cupula and ciliary bundle, causes a depolarization of the hair cells.
Since hair cells are innervated by sensory neurons (afferent neurons), this depolarization
is passed on to the sensory neurons which transmit information regarding the movement to the
central nervous system (CNS) (Chitnis et al., 2012). When the brain processes this stimulus, it
sends a signal back to the hair cells as well as to muscles to move in response to the stimuli via
efferent neurons. Zebrafish use their lateral line system to translate water current stimuli into
signals that lead to behaviors such as obstacle and/or predator avoidance, schooling, or
orientation to a water current (Montgomery et al., 1997).
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Figure 4. Structure and innervation of a hair cell. Hair cells are embedded within a gelatinous
cupula that is in contact with water. In the event of water movement, cupulas bend in the direction
of the stimuli. The movement in both cupulas and ciliary bundles causes a depolarization. This
depolarization is passed onto sensory neurons via afferent fibers. When the brain processes this
stimulus, a signal is sent back to the hair cells via efferent fibers. Adapted from Current Biology.

The lateral line system can be broken down into two parts: the anterior lateral line (ALL)
and the posterior lateral line (PLL). Neuromasts on the head of the fish form the ALL whereas
neuromasts extending from the head towards the tip of the tail, form the PLL (Ghysen et al.,
2012). The posterior lateral line develops from a placode near the otic (ear) vesicle. Placodes are
formed during embryonic development from thickenings of the surface cells (ectoderm) and
eventually give rise to cranial ganglia and olfactory epithelium. In the case of the lateral line
placode, cells from the placode will detach from and begin migrating to form the posterior lateral
line primordium (PLLP). In doing so, the cells will migrate along a path following the horizontal
myoseptum, a layer of connective tissue separating the dorsal (back) and ventral (belly)
musculature and travel to the tip of the tail.
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As the PLL primordium migrates, neuromasts are deposited along the way (Figure 5)
(Ghysen et al., 2004). The cells that remain in the PLL placode are used to form the neurons of
the lateral line ganglion, which will serve as the communication center between the brain and
neuromasts. Sensory neurons in the lateral line ganglion extend growth cones that follow the
migrating primordium to innervate the sensory hair cells of deposited neuromasts. This process
gives rise to the lateral line sensory system and its mechanosensory structure (Metcalfe et al.,
1985; Chitnis et al., 2012).

Figure 5. Posterior lateral line (PLL) development. Neuromasts extending from the head
towards the tip of the tail form the PLL. The PLL develops from a placode near the otic (ear)
vesicle. Cells from the placode will detach from and begin migrating to form the posterior lateral
line primordium (PLLP). As the PLL primordium migrates, neuromasts are deposited along the
way. The cells that remain in the PLL placode are used to form the neurons of the lateral line
ganglion. Adapted from Current Biology.
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1.3. CXCL12-CXCR4 and lateral line development
In zebrafish, the CXCL12-CXCR4 signaling pathway plays an important role in lateral
line development. For the posterior lateral line primordium to migrate from just posterior of the
otic (ear) vesicle to the tip of the tail, chemokine signaling must occur. CXCR4, located on the
surface of migrating cells, binds to CXCL12, which is found along the horizontal myoseptum.
The presence of CXCL12 is attributed with providing a prospective pathway for the primordium
to migrate on and to establish where the posterior lateral line will develop (Ghysen et al., 2004).
This is due to CXCL12’s chemotactic nature. In studies, it has been found that loss of CXCL12
expression results in failure of the PLL primordium to migrate along the horizontal myoseptum
(Ghysen et al., 2004; Valentin et al., 2007).
Given the importance of the lateral line system as a mechanosensory structure and
CXCL12’s role in its formation, it is important to understand how signaling pathways such as the
CXCL12-CXCR4 is regulating PLL development. In recent years, researchers have discovered
that CXCL14 interacts with CXCR4 to modulate CXCL12-mediated chemotaxis in other
biological contexts. This suggests that CXCL14 can function this way during development to
regulate the CXCL12-CXCR4 signaling pathway. In our lab, we are focused on whether
CXCL14 regulates lateral line development by attenuating the migratory signal mediated through
CXCL12-CXCR4 signaling pathways via allosteric modulation.
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MATERIALS AND METHODS
2.1. Zebrafish husbandry
Zebrafish (Danio rerio) of the AB wildtype-strain were obtained from ZIRC- Zebrafish
International Resource Center (Eugene, OR, USA) and housed in six separate 2.8-liter tanks
(Aquaneering, San Diego, CA, USA). Each tank housed three males and three females. Tanks
were separated according to birthdates. Zebrafish were maintained at 28.5°C with a 10-hours
dark, 14-hours light cycle. Zebrafish were fed TetraMin tropical flakes (Blacksburg, VA, USA)
ad libitum and had continuous access to filtered, aged tap water using the Pentair Shurflo water
pump (Minneapolis, MN, USA) and Aquaneering water filter system (San Diego, CA, USA).
Embryos were incubated in 1x E3 buffer at 28.5°C. Developmental stages were determined by
embryo morphology and hours post-fertilization (hpf). See Appendices 1 and 2 for detailed
protocols.

2.2. Microinjection
Zebrafish embryos were injected at the one-cell stage with 1 nl of 0.3 uM CXCL14
antisense morpholino (MO) in phenol red buffer (5- CCGTACTACAGCGATTCATCCCCAA3’). CXCL14-MO was obtained from Gene Tools (Gene Tools LLC., Philomath, OR, USA)
(Appendix 2). For controls, zebrafish embryos were microinjected with 1 nl phenol red buffer
and, as an additional control, not microinjected. Zebrafish embryos were maintained at 28.5ºC
for a series of three incubation periods: 24 hours post-fertilization, 36 hours post-fertilization,
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and 48 hours post-fertilization, at which time viable embryos were assessed and total RNAs
were extracted. See Appendices 2 and 3 for detailed protocols.

2.3. Primer Design
Two different sets of gene specific primer pairs were designed using NCBI PrimerBLAST (National Center for Biotechnology Information, Rockville Pike, MD, USA). To
examine whether CXCL14 knock-down affects gene expression, we designed primer pairs based
off possible genes affected by, or downstream of, either CXCL14 or CXCL12. This set of gene
specific primer pairs were used for qPCR as follows: β-actin and GAPDH were used as reference
control genes whereas NF-kB, SCX-a, pmp22-b, mpz, mbp, OSR1, OSR2, and COL17-A1b
were target genes of interest (Table 1).
Based off inconclusive data from primer set #1 (Appendix 5), the research question was
reformulated to examine the relationship between CXCL14 knock-down and embryonic
development. To determine whether CXCL14 knock-down affects gene expression, we designed
primers based off genes expressed during lateral line development. This set of gene specific
primer pairs were used for qPCR as follows: β-actin was used as the reference gene whereas
CXCL14-a, CXCL12-a, CXCR4-b, CXCR7-b, snail-1b, cldn-2, and epcam were target genes of
interest (Table 2). See Appendices 4 and 5 for detailed protocols.
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Primer Design Set #1: Sequence Information
Fragment

Gene

Forward Primer

Reverse Primer

Control

B-actin

5-TCACCACCACAGCCGAAAG-3

5-AGAGGCAGCGGTTCCCAT-3

98bp

Control

GAPDH

5-GTGTAGGCGTGGACTGTGGT-3

5-TGGGAGTCAACCAGGACAAATA-3

121bp

NF-kB

5-GCTCCAGGATGACGTTCAGTA-3

5-CCAGAAAGTCCCGTTGAGGT-3

201 bp

SCX-a

5-TCAGGGAGGGATGAGAGCAG-3

5-TCTGCTCCAGAGAACCGAGA-3

335 bp

Pmp22-b

5-TGGAAACGAGGAGCAGAACC-3

5-AGTGAACCTGAGAGGAGGGT-3

496 bp

Mpz

5-ATTGCGTCCTTAGCCCCATC-3

5-GTGTTTGTATCCTCCAGCCTCT-3

177 bp

Mbp

5-TGTCCGAGTCAAGTTGCTACA-3

5-GCTTTTGGTTGGGCAGTCAG-3

316 bp

OSR1

5-CCTCAATCCCACTGTTCCCC-3

5-AGGCAGGTATGAGCAGGAATG-3

484 bp

OSR2

5-AGTCTTACTGCCCATTCCCG-3

5-AACCGCTCAAACTGTGTGTTTC-3

116 bp

COL17A1b

5-TCACTTTGTCACTAATGCCGAT-3

5-TCACCCTTTTCTCCCCTTGG-3

327 bp

DT
of

size

CXCL14

DT
of
CXCL12

Table 1. Sequence information for primer pair set #1. Primer pair sequences were designed
for genes potentially affected by, or downstream of, either CXCL12 or CXCL14. These primer
pairs were used for qPCR experiments. All primer pairs were designed using NCBI Primer
BLAST. For more information, see Appendix 4.
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Primer Design Set #2: Sequence Information
Gene

Forward Primer

Reverse Primer

Fragment
size

Control

B-actin

5’-TCACCACCACAGCCGAAAG-3’

5-AGAGGCAGCGGTTCCCAT-3

98bp

Control

GAPDH

5’-GTGTAGGCGTGGACTGTGGT-3’

5’-TGGGAGTCAACCAGGACAAATA-3’

CXCL14-a

5'-TGCAGATGCACAAGAAAAGG-3’

5'-GGCTTCAAACGTCCTGTGTT-3’

225 bp

CXCL12-a

5'-TTCATGCACCGATTTCCAAC-3’

5'-TGTTGATGGCGTTCTTCAGG-3’

222 bp

CXCR4-b

5'-TACGATGTAAGTTGGCTTGTGA-3’

5'-CTGACTGAGAGGTCGCAAAG-3’

435 bp

CXCR7-b

5'-GAGTTGCCACCACACAAAGG-3’

5'-TGTGCTTAATTGGTCCCTGC-3’

396 bp

Cldn-2

5'-GCGTTTTATTGATTTGCAGGCG-3’

5'-TTGCTGCCCGTTTTATGTGC-3’

353 bp

Snail-1b

5'-CGCTGAAGTTTCGAGGGGAT-3’

5'-CAGTGTTTGCAGTGGAAGGC-3’

485 bp

Epcam

5'-CTGCCCCTGTTTTGGAATGG-3’

5'-GCGTTTGGAAAACGAGACCTT-3’

375 bp

Ligands

Receptors

Genes
expressed in
neuromasts
and
primordium

121 bp

Table 2. Sequence information for primer pair set #2. Primer pair sequences were designed
for genes expressed during lateral line development. These primer pairs were used for qPCR
experiments. All primer pairs were designed using NCBI Primer BLAST. For more information,
see Appendix 4.
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2.4. Real-time quantitative polymerase chain reaction (RT-qPCR)
Total RNAs were extracted from 50 embryos at various embryonic stages: 24, 36, and 48
hpf using Trizol (Zymo Research, Irvine, CA, USA) reagent. RNA concentrations and purity
were determined using the NanoDrop 2000 (Thermo Fisher Scientific, Waltham, MA, USA).
Complementary DNA strands (cDNAs) were synthesized from 1.5 ug of total RNA using the
Easy-script reverse transcription system (Lamda Biotech Corporation, Ballwin, MO, USA).
cDNAs were then amplified with gene specific primers and SYBR green reagents (Promega
Corporation, Madison, WI, USA) in a 7500 real-time quantitative PCR system (Applied
Biosystems, Foster City, CA, USA).
Quantitative polymerase chain reactions were used to quantify mRNA gene expression in
each sample by measuring emitted fluorescence intensity. Reactions were performed under the
following cycling conditions: pre-denaturation at 95ºC for 10 minutes, followed by 40 cycles of
95ºC for 15 seconds and 60ºC for 1 minute, then a melting curve cycle at 95ºC for 15 seconds,
60ºC for 1 minute, 95ºC for 30 seconds, and 60ºC for 15 seconds to conﬁrm ampliﬁcation
speciﬁcity. Reactions were conducted as single runs, duplicates, and triplicates (Appendix 4).
qPCR results were used to calculate the variation of gene expression between two samples, also
known as “relative gene expression.” Amplification products were then electrophoresed on 1%
agarose gels. See Appendix 4 for detailed protocols and Tables 1 and 2 for primer pairs.

2.5. Calculations and statistical analysis
Relative gene expression levels for each sample were determined using the 2-Ct method
with either GAPDH or β-actin as the reference gene. CT values were averaged to calculate means
and standard deviation of means per sample. To compare the effects of microinjection on gene
23

expression, data were presented as Log2 mRNA fold-change levels of sham-injected embryos
relative to non-injected embryos. To compare the effects of morpholino knock-down on gene
expression, data were presented as Log2 mRNA fold-change levels of morpholino-injected
embryos relative to sham-injected embryos. All numerical data are presented as relative gene
expression ± standard deviation.
CT values were transformed and analyzed by a Mann-Whitney test to determine the
statistically significant difference between non-injected and sham-injected embryos. CT values
were also transformed and analyzed by a Mann-Whitney test to determine the statistically
significant difference between sham-injected embryos and morpholino-injected embryos. Pvalues were calculated assuming non-parametric distribution due to limited numbers of samples.
All data were analyzed using GraphPad Prism 8 software (GraphPad Software, San Diego, CA,
USA). See Appendix 4 for detailed protocols.
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RESULTS
3.1. Gel electrophoresis for amplified PCR products
Gel electrophoresis was used to determine RNA and primer pair quality. For RNA gel
electrophoresis, the 18S rRNA and 16S rRNA bands are clearly depicted at 1550 bp and 1000
bp, respectively. Clear and distinct bands indicate RNA purity, which coincides with NanoDrop
results. There does not appear to be any RNA degradation or impurities, therefore the RNA
extracted from each time point were used for cDNA synthesis reactions.

Figure 6. Gel Electrophoresis for RNA samples from Danio rerio zebrafish at 24, 36, and 48
hpf. The DNA ladder is displayed as “L.” RNA extracted from non-injected embryos at 24 hpf are
displayed as N-24. RNA extracted from sham-injected and morpholino-injected embryos at 24 hpf
are displayed as S-24 and M-24, respectively. RNA extracted from non-injected embryos at 36 hpf
are displayed as N-36. RNA extracted from sham-injected and morpholino-injected embryos at 36
hpf are displayed as S-36 and M-36, respectively. RNA extracted from non-injected embryos at
48 hpf are displayed as N-48. RNA extracted from sham-injected and morpholino-injected
embryos are displayed as S-48 and M-48, respectively. N=50.
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Figure 7. B-actin gel electrophoresis for Danio rerio zebrafish at 24, 36, and 48 hpf. The DNA
ladder is displayed as “L.” RNA extracted from non-injected embryos at 24 hpf are displayed as
N-24. RNA extracted from sham-injected and morpholino-injected embryos at 24 hpf are
displayed as S-24 and M-24, respectively. RNA extracted from non-injected embryos at 36 hpf are
displayed as N-36. RNA extracted from sham-injected and morpholino-injected embryos at 36 hpf
are displayed as S-36 and M-36, respectively. RNA extracted from non-injected embryos at 48 hpf
are displayed as N-48. RNA extracted from sham-injected and morpholino-injected embryos are
displayed as S-48 and M-48, respectively. N=50.

Figure 8. CXCL12 gel electrophoresis for Danio rerio zebrafish at 24, 36, and 48 hpf. The
DNA ladder is displayed as “L.” RNA extracted from non-injected embryos at 24 hpf are displayed
as N-24. RNA extracted from sham-injected and morpholino-injected embryos at 24 hpf are
displayed as S-24 and M-24, respectively. RNA extracted from non-injected embryos at 36 hpf are
displayed as N-36. RNA extracted from sham-injected and morpholino-injected embryos at 36 hpf
are displayed as S-36 and M-36, respectively. RNA extracted from non-injected embryos at 48 hpf
are displayed as N-48. RNA extracted from sham-injected and morpholino-injected embryos are
displayed as S-48 and M-48, respectively. N=50.
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Figure 9. CXCL14 gel electrophoresis for Danio rerio zebrafish at 24, 36, and 48 hpf. The
DNA ladder is displayed as “L.” RNA extracted from non-injected embryos at 24 hpf are displayed
as N-24. RNA extracted from sham-injected and morpholino-injected embryos at 24 hpf are
displayed as S-24 and M-24, respectively. RNA extracted from non-injected embryos at 36 hpf are
displayed as N-36. RNA extracted from sham-injected and morpholino-injected embryos at 36 hpf
are displayed as S-36 and M-36, respectively. RNA extracted from non-injected embryos at 48 hpf
are displayed as N-48. RNA extracted from sham-injected and morpholino-injected embryos are
displayed as S-48 and M-48, respectively. N=50.
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3.2. Quantifying the effect of microinjection on gene expression
The aim of this study was to examine the effects of CXCL14 knock-down on Danio rerio
gene expression during lateral line development. In order to test our methodology, we first
analyzed the relationship between microinjections and gene expression. Subsequently, zebrafish
embryos were microinjected with 1 nl of phenol red buffer without morpholino (sham-injected).
Microinjected embryos were compared to non-injected embryos at 24, 36, and 48 hpf. RT-qPCR
was used to determine the mRNA levels of seven zebrafish genes expressed at various time
points during lateral line development: CXCL12, CXCL14, CXCR4, CXCR7, snail-1b, cldn-2,
and epcam. Relative gene expression levels were presented as Log2 mRNA levels of shaminjected embryos relative to non-injected embryos.

Figure 10. Effect of Microinjection on Gene Expression in Danio rerio embryos at 24 hpf.
RT-qPCR examined the mRNA levels of seven zebrafish genes: CXCL12, CXCL14, CXCR4,
CXCR7, snail-1b, cldn-2, and epcam expressed at 24 hours post-fertilization (hpf) following
microinjection with 1 nl of phenol red. Relative gene expression levels were determined using the
2-Ct method with β-actin as the reference gene. The statistical significance of the data was
determined by a two-tailed Mann-Whitney test between non-injected and sham-injected embryos
at 24 hpf. Results were expressed as Log2 mRNA fold-change values ± S.D. (n = 6), *P  0.05.
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Although the data were not statistically significant, it was observed that microinjection
with phenol red caused a notable shift in gene expression at 24 hpf (Figure 10). When compared
to the control (non-injected embryos), sham-injections resulted in a decrease in CXCL12,
CXCR7, and snail-1b gene expression. More specifically, average mRNA levels for CXCL12
decreased by 2.17-fold: control (n=6, 𝑥̅ = 0-fold change ± 4.734), sham-injection (n=6, 𝑥̅ = 2.17fold change ± 7.979, p= 0.818). Moreover, average mRNA levels decreased by 4.6-fold for
CXCR7: control (n=6, 𝑥̅ = 0-fold change ± 3.609), sham-injection (n=6, 𝑥̅ = 4.6-fold change ±
4.226, p= 0.818) and by 22.7-fold for snail-1b following microinjection: control (n=6, 𝑥̅ = 0-fold
change ± 5.731), sham-injected (n=6, 𝑥̅ = 22.7-fold change ± 5.902, p= 0.309).
Conversely, it was also observed that sham-injections caused an increase in gene
expression at 24 hpf (Figure 10). When compared to the control (non-injected embryos), shaminjections resulted in an increase in CXCL14 and epcam gene expression. Specifically, average
mRNA levels for CXCL14 increased by 15.2-fold: control (n= 6, 𝑥̅ = 0-fold change ±10.647),
sham-injected (n=6, 𝑥̅ = 15.2-fold change ± 8.617, p= 0.24) and by 49.6-fold for epcam following
microinjection: control (n= 6, 𝑥̅ = 0-fold change ± 6.346), sham-injected (n= 6, 𝑥̅ = 49.6-fold
change ± 7.784, p= 0.179).
When compared to the control, however, CXCR4 mRNA levels did not demonstrate a
significant decrease in gene expression: control (n= 6, 𝑥̅ = 0-fold change ± 2.391), sham-injected
embryos (n=6, 𝑥̅ = 1.22-fold change ± 1.446, p= 0.815). Similarly, cldn-2 mRNA levels did not
demonstrate a significant increase in gene expression following microinjection: control (n=6, 𝑥̅ =
0-fold change ± 6.346), sham-injected embryos (n=6, 𝑥̅ = 0.869-fold change ± 0.55, p= 1.159).
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Figure 11. Effect of Microinjection on Gene Expression in Danio rerio embryos at 36 hpf.
RT-qPCR examined the mRNA levels of seven zebrafish genes: CXCL12, CXCL14, CXCR4,
CXCR7, snail-1b, cldn-2, and epcam expressed at 36 hours post-fertilization (hpf) following
microinjection with 1 nl of phenol red. Relative gene expression levels were determined using
the 2-Ct method with β-actin as the reference gene. The statistical significance of the data was
determined by a two-tailed Mann-Whitney test between non-injected and sham-injected embryos
at 36 hpf. Results are expressed as Log2 fold-change values ± S.D. (n = 6), *P 0.05

Although the data were not statistically significant, it was observed that microinjection
with phenol red caused a notable shift in gene expression at 36 hpf (Figure 11). When compared
to the control (non-injected embryos), sham-injections resulted in increased gene expression for
both CXCL12 and CXCR7. Average mRNA levels for CXCL12 increased by 2.1-fold (control:
n=6, 𝑥̅ = 0-fold change ± 2.374; sham-injection: n=6, 𝑥̅ = 2.1-fold change ± 3.087, p= 0.177)
whereas CXCR7 gene expression increased by 10.1-fold (control: n=6, 𝑥̅ = 0-fold change ± 7.159;
sham-injected: n=6, 𝑥̅ = 10.1-fold change ± 2.95, p= 0.428).
However, when compared to the control (non-injected embryos), CXCR4 mRNA levels
did not demonstrate a significant increase in gene expression: control (n=6, 𝑥̅ = 0-fold change ±
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2.029), sham-injection (n=6, 𝑥̅ = 1.86-fold change ± 2.986, p= 0.093). Likewise, cldn-2 mRNA
levels did not demonstrate a significant increase in gene expression following microinjection:
control (n= 6, 𝑥̅ = 0-fold change ± 2.648), sham-injected (n= 6, 𝑥̅ = 1.29-fold change ± 3524, p=
0.121).
In contrast, it was also observed that sham-injections caused a decrease in snail-1b gene
expression at 36 hpf: control (n=6, 𝑥̅ = 0-fold change ± 5.843), sham-injected (n=6, 𝑥̅ = 22-fold
change ± 6.769, p= 0.818). Although similar trends were demonstrated, CXCL14 and epcam
mRNA levels did not demonstrate a significant decrease in gene expression when compared to
the control (non-injected embryos). Specifically, average mRNA levels for CXCL14 only
decreased by 1.16-fold: control (n= 6, 𝑥̅ = 0-fold change ± 4.601), sham-injected (n=6, 𝑥̅ = 1.16fold change ± 8.989, p= 0.428). Similarly, epcam gene expression only decreased by 1.44-fold:
control (n= 6, 𝑥̅ = 0-fold change ± 8.512), sham-injected (n= 6, 𝑥̅ = 1.44-fold change ± 7.874, p=
0.699).
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Figure 12. Effect of Microinjection on Gene Expression in Danio rerio embryos at 48 hpf.
RT-qPCR examined the mRNA levels of seven zebrafish genes: CXCL12, CXCL14, CXCR4,
CXCR7, snail-1b, cldn-2, and epcam expressed at 48 hours post-fertilization (hpf) following
microinjection with 1 nl of phenol red. Relative gene expression levels were determined using
the 2-Ct method with β-actin as the reference gene. The statistical significance of the data was
determined by a two-tailed Mann-Whitney test between non-injected and sham-injected embryos
at 48 hpf. Results are expressed as Log2 fold-change values ± S.D. (n = 6), *P 0.05.

Although the data were not statistically significant, it was observed that microinjection
with phenol red caused a notable shift in gene expression at 48 hpf (Figure 12). When compared
to the control (non-injected embryos), sham-injections resulted in an increase in gene expression
for CXCL14, snail-1b, and epcam. More specifically, average mRNA levels for CXCL14
increased by 3.06-fold (control: n=6, 𝑥̅ = 0-fold change ± 6.39), sham-injected (control: n=6, 𝑥̅ =
3.06-fold change ± 7.797, p= 0.064). Moreover, following microinjection, average mRNA levels
for snail-1b increased by 3.25-fold: control (n= 6, 𝑥̅ = 0-fold change ± 7.05), sham-injected (n=6,
𝑥̅ = 3.25-fold change ± 5.782, p= 0.937) and by 4963-fold for epcam: control (n= 6, 𝑥̅ = 0-fold
change ± 9.414), sham-injected (n= 6, 𝑥̅ = 4963-fold change ± 9.851, p= 0.309). When compared
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to the control (non-injected embryos), however, cldn-2 mRNA levels did not demonstrate a
significant increase in gene expression: control (n=6, 𝑥̅ = 0-fold change ± 1.699), sham-injected
(n=6, 𝑥̅ = 1.75-fold change ± 2.465, p= 0.66).
Conversely, it was also observed that sham-injections caused a decrease in CXCR4 gene
expression: control (n=6, 𝑥̅ = 0-fold change ±3.868), sham-injected (n=6, 𝑥̅ = 2.33-fold change ±
2.192, p= 0.699). Although similar trends were demonstrated, CXCL12 and CXCR7 mRNA
levels did not demonstrate a significant decrease in gene expression when compared to the
control (non-injected embryos). Specifically, average mRNA levels for CXCL12 only decreased
by 1.2-fold: control (n= 6, 𝑥̅ = 0-fold change ± 0.866), sham-injected (n=6, 𝑥̅ = 1.2-fold change ±
5.100, p= 0.536) and by 1.36-fold for CXCR7: control (n= 6, 𝑥̅ = 0-fold change ± 5.172), shaminjected (n= 6, 𝑥̅ = 1.36-fold change ± 5.337, p= 0.393).
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Summary of mRNA fold-change values relative to non-injected embryos
24 hpf

36 hpf

48 hpf

CXCL12

Decrease in gene
expression by
2.17-fold ± 7.979.
p= 0.818

Increase in gene
expression by
2.1-fold ± 3.08.
p= 0.177

Decrease in gene
expression by
1.2-fold ± 5.100.
p= 0.536

CXCL14

Increase in gene
expression by
15.2-fold ± 8.617.
p= 0.24

Decrease in gene
expression by
1.16-fold ± 8.989.
p= 0.428

Increase in gene
expression by
3.06-fold ± 7.797.
p= 0.064

CXCR4

Decrease in gene
expression by
1.22-fold ± 1.446.
p= 0.815

Increase in gene
expression by
1.86-fold ± 2.986.
p= 0.093

Decrease in gene
expression by
2.33-fold ± 2.192.
p= 0.699

CXCR7

Decrease in gene
expression by
4.6-fold ± 4.226.
p= 0.818

Increase in gene
expression by
10.1-fold ± 2.95.
p= 0.428

Decrease in gene
expression by
1.36-fold ± 5.337.
p= 0.393

Snail-1b

Decrease in gene
expression by
22.7-fold ± 5.902.
p= 0.309

Decrease in gene
expression by
22-fold ± 6.769.
p= 0.818

Increase in gene
expression by
3.25-fold ± 5.782.
p= 0.937

Cldn-2

Increase in gene
expression by
0.869-fold ± 0.55.
p= 1.159

Increase
in gene expression by
1.29-fold ± 3524.
p= 0.121

Increase in gene
expression by
1.75-fold ± 2.465.
p= 0.66

Epcam

Increase in gene
expression by
49.6-fold ± 7.784.
p= 0.179

Decrease in gene
expression by
1.44-fold ± 7.874.
p= 0.699

Increase in gene
expression by
4963-fold ± 9.851.
p= 0.309

Table 3. Summary of mRNA fold-change values for sham-injected embryos relative to noninjected embryos. Data were presented as fold-change in gene expression ± S.D. *P  0.05.

It is interesting to note the impact microinjections have on gene expression. Although
none of the data were statistically significant, there is evidence to support that microinjections
can affect gene expression (Table 3). Given sham-injection’s ability to interfere with gene
expression, we decided to compare data from morpholino-injected embryos relative to sham34

injected embryos. This allowed us the opportunity to analyze the difference in injection contents
and their respective impact on gene expression.

3.3. Quantifying the effect of morpholino injection on gene expression
Upon analyzing the effects of microinjection on gene expression, we examined the
relationship between CXCL14 knock-down and Danio rerio gene expression during lateral line
development. As a result, zebrafish embryos were microinjected with 1 nl of CXCL14 antisense
morpholino in phenol red buffer. Morpholino-injected embryos were compared to sham-injected
embryos at 24, 36, and 48 hpf. RT-qPCR was used to determine the mRNA levels of seven
zebrafish genes expressed at various time points during lateral line development: CXCL12,
CXCL14, CXCR4, CXCR7, snail-1b, cldn-2, and epcam. Relative gene expression levels were
presented as Log2 mRNA levels of morpholino-injected embryos relative to sham-injected
embryos.
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Figure 13. Effect of Morpholino injections on Gene Expression in Danio rerio embryos at
24 hpf. RT-qPCR examined the mRNA levels of seven zebrafish genes: CXCL12, CXCL14,
CXCR4, CXCR7, snail-1b, cldn-2, and epcam expressed at 24 hours post-fertilization (hpf)
following microinjection with either 1 nl of phenol red (sham) or CXCL14 antisense morpholino
in phenol red buffer. Relative gene expression levels were determined using the 2-Ct method
with β-actin as the reference gene. The statistical significance of the data was determined by a
two-tailed Mann-Whitney test between sham-injected embryos and morpholino-injected embryos
at 24 hpf. Results were expressed as Log2 fold-change values ± S.D. (n = 6), *P 0.05

When compared to the control (sham-injected embryos), it was observed that
microinjection with CXCL14 antisense morpholino caused a notable increase in gene expression
at 24 hpf for five out of the seven genes: CXCL12, CXCR4, CXCR7, snail-1b, and cldn-2 (Figure
13). After microinjection with CXCL14 antisense morpholino, average mRNA levels increased
by 3.78-fold for CXCR4: control (n=6, 𝑥̅ = 0-fold change ± 1.446), morpholino-injection (n=6, 𝑥̅ =
3.78-fold change ± 1.09, p= 0.309), by 3.78-fold for CXCR7: control (n=6, 𝑥̅ = 0-fold change ±
4.226), morpholino-injected (n=6, 𝑥̅ = 3.78-fold change ± 2.023, p= 0.937), and by 267-fold for
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snail-1b: control (n=6, 𝑥̅ = 0-fold change ± 5.902), morpholino-injected (n=6, 𝑥̅ = 267-fold
change ± 6.823, p= 0.179). In particular, CXCL12 gene expression following morpholinoinjections were statistically significant from embryos receiving sham-injections. In comparison
to controls, average mRNA levels for CXCL12 increased by 12.6-fold: control (n=6, 𝑥̅ = 0-fold
change ± 7.979), morpholino-injection (n=6, 𝑥̅ = 12.6-fold change ± 1.147, *p= 0.026).
Moreover, cldn-2 gene expression following morpholino-injections demonstrated a 3.78-fold
increase with a modest p-value of 0.056: control (n=6, 𝑥̅ = 0-fold change ± 0.550), morpholinoinjected (n=6, 𝑥̅ = 3.78-fold change ± 2.434, p= 0.056).
Compared to the control (sham-injected embryos), CXCL14 and epcam mRNA levels did
not demonstrate a significant change in gene expression. Following morpholino-injections,
CXCL14 only demonstrated a 0.99-fold increase in gene expression: control (n=6, 𝑥̅ = 0-fold
change ± 8.617), morpholino-injected (n=6, 𝑥̅ = 0.99-fold change ± 3.596, p= 0.588). Likewise,
epcam mRNA levels only decreased by 1.44-fold following morpholino-injections: control (n=6,
𝑥̅ = 0-fold change ± 7.784), morpholino-injected (n= 6, 𝑥̅ = 1.44-fold change ± 8.23, p= 0.699).
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Figure 14. Effect of Morpholino injections on Gene Expression in Danio rerio embryos at
36 hpf. RT-qPCR examined the mRNA levels of seven zebrafish genes: CXCL12, CXCL14,
CXCR4, CXCR7, snail-1b, cldn-2, and epcam expressed at 36 hours post-fertilization (hpf)
following microinjection with either 1 nl of phenol red (sham) or CXCL14 antisense morpholino
in phenol red buffer. Relative gene expression levels were determined using the 2-Ct method
with β-actin as the reference gene. The statistical significance of the data was determined by a
two-tailed Mann-Whitney test between sham-injected embryos and morpholino-injected embryos
at 36 hpf. Results were expressed as Log2 fold-change values ± S.D. (n = 6), *P 0.05

When compared to the control (sham-injected embryos), it was observed that
microinjection with CXCL14 antisense morpholino caused a notable increase in gene expression
at 36 hpf (Figure 14). More specifically, average mRNA levels increased by 5.37-fold for
CXCL14: control (n=6, 𝑥̅ = 0-fold change ± 8.989), morpholino-injection (n=6, 𝑥̅ = 5.37-fold
change ± 8.342, p= 0.792), by 26.6-fold for snail-1b: control (n=6, 𝑥̅ = 0-fold change ± 6.769),
morpholino-injected (n=6, 𝑥̅ = 26.6-fold change ± 4.981, p= 0.699), and by 2.47-fold for epcam:
control (n=6, 𝑥̅ = 0-fold change ± 7.874), morpholino-injected (n=6, 𝑥̅ = 2.47-fold change ±
8.403, p= 0.309).
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In contrast, it was also observed that mRNA levels decreased following morpholinoinjections. In particular, CXCR7 and cldn-2 gene expression for morpholino-injected embryos
were statistically significant from embryos receiving sham-injections When compared to the
control, average mRNA levels decreased by 25.6-fold for CXCR7: control (n=6, 𝑥̅ = 0-fold
change ± 2.95), morpholino-injected (n=6, 𝑥̅ = 25.6-fold change ± 0, *p= 0.017) and by 1.75-fold
for cldn-2: control (n=6, 𝑥̅ = 0-fold change ± 3.524), morpholino-injected (n=6, 𝑥̅ = 1.75-fold
change ± 2.658, *p= 0.036). Although similar trends were demonstrated, mRNA levels for both
CXCL12 and CXCR4 only decreased by less than 2-fold. Following morpholino-injections, gene
expression decreased by 1.85-fold for CXCL12: control (n=6, 𝑥̅ = 0-fold change ± 3.087),
morpholino-injected: (n=6, 𝑥̅ = 1.85-fold change ± 1.993, p= 0.930) and by 1.08-fold for CXCR4:
control (n=6, 𝑥̅ = 0-fold change ± 2.986), morpholino-injected: (n=6, 𝑥̅ = 1.08-fold change ± 2.36,
p= 0.179).
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Figure 15. Effect of Morpholino injections on Gene Expression in Danio rerio embryos at
48 hpf. RT-qPCR examined the mRNA levels of seven zebrafish genes: CXCL12, CXCL14,
CXCR4, CXCR7, snail-1b, cldn-2, and epcam expressed at 48 hours post-fertilization (hpf)
following microinjection with either 1 nl of phenol red (sham) or CXCL14 antisense morpholino
in phenol red. Relative gene expression levels were determined using the 2-Ct method with βactin as the reference gene. The statistical significance of the data was determined by a twotailed Mann-Whitney test between non-injected embryos and either sham-injected or
morpholino-injected embryos at 48 hpf. Results were expressed as Log2 fold-change values ±
S.D. (n = 6), *P 0.05

When compared to the control (sham-injected embryos), it was observed that
microinjection with CXCL14 antisense morpholino caused a notable increase in gene expression
at 48 hpf (Figure 15). More specifically, average mRNA levels increased by 49.3-fold for
CXCR7: control (n=6, 𝑥̅ = 0-fold change ± 5.337), morpholino-injected: (n=6, 𝑥̅ = 49.3-fold
change ± 6.655, p= 0.179), by 8.9-fold for snail-1b: control (n=6, 𝑥̅ = 0-fold change ± 5.782),
morpholino-injected: (n=6, 𝑥̅ = 8.9-fold change ± 7.866, p= 0.484), and by 3.68-fold for cldn-2:
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control (n=6, 𝑥̅ = 0-fold change ± 2.465), morpholino-injected (n=6, 𝑥̅ = 3.68-fold change ±
6.014, p= 0.937). Although similar trends were demonstrated, average mRNA levels for CXCL14
only increased by 1.71-fold: control (n=6, 𝑥̅ = 0-fold change ± 7.797), morpholino-injected (n=6,
𝑥̅ = 1.71-fold change ± 3.74, p= 0.662). Similarly, when compared to the control, average mRNA
levels for epcam only increased by 1.99-fold: control (n=6, 𝑥̅ = 0-fold change ± 9.851),
morpholino-injected (n=6, 𝑥̅ = 1.99-fold change ± 7.986, p= 0.484).
In contrast, it was also observed that mRNA levels were not affected by morpholinoinjections at 48 hpf. In particular, CXCL12 and CXCR4 average mRNA levels experienced a
small decrease in expression (< 2-fold). More specifically, when compared to the control (shaminjected embryos), CXCL12 gene expression only decreased by 1.07-fold: control (n=6, 𝑥̅ = 0fold change ± 5.100), morpholino-injected (n=6, 𝑥̅ = 1.07-fold change ± 2.083, p= 0.547).
Likewise, following morpholino-injections, CXCR4 mRNA levels only decreased by 1.21-fold:
control (n=6, 𝑥̅ = 0-fold change ± 2.192), morpholino-injected (n=6, 𝑥̅ = 1.21-fold change ±
2.408, p= 0.309).
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Summary of mRNA fold-change values relative to sham-injected embryos
24 hpf

36 hpf

48 hpf

CXCL12

Increase in gene
expression by
12.6-fold ± 1.147.
*p= 0.026

Decrease in gene
expression by
1.85-fold ± 1.993.
p= 0.930

Decrease in gene
expression by
1.07-fold ± 2.083.
p= 0.547

CXCL14

Increase in gene
expression by
0.99-fold ± 3.596.
p= 0.588

Increase in gene
expression by
5.37-fold ± 8.342.
p= 0.792

Increase in gene
expression by
1.71-fold ± 3.74.
p= 0.662

CXCR4

Increase in gene
expression by
3.78-fold ± 1.09.
p= 0.309

Decrease in gene
expression by
1.08-fold ± 2.36.
p= 0.179

Decrease in gene
expression by
1.21-fold ± 2.408.
p= 0.309

CXCR7

Increase in gene
expression by
3.78-fold ± 2.023.
p= 0.937

Decrease in gene
expression by
25.6-fold ± 0.
*p= 0.017

Increase in gene
expression by
49.3-fold ± 6.655.
p= 0.179

Snail-1b

Increase in gene
expression by
267-fold ± 6.823.
p= 0.179

Increase in gene
expression by
26.6-fold ± 4.981.
p= 0.699

Increase in gene
expression by
8.9-fold ± 7.866.
p= 0.484

Cldn-2

Increase in gene
expression by
3.78-fold ± 2.434.
p= 0.056

Decrease in gene
expression by
1.75-fold ± 2.658.
*p= 0.036

Increase in gene
expression by
3.68-fold ± 6.014.
p= 0.937

Epcam

Decrease in gene
expression by
1.44-fold ± 8.23.
p= 0.699

Increase in gene
expression by
2.47-fold ± 8.403.
p= 0.309

Increase in gene
expression by
1.99-fold ± 7.986.
p= 0.484

Table 4. Summary of mRNA fold-change values for CXCL14 antisense morpholino-injected
embryos relative to sham-injected embryos. Data were presented as fold-change in gene
expression ± S.D. *P  0.05.

42

DISCUSSION
The aim of this study was to examine the effects of CXCL14 knock-down on Danio rerio
gene expression during lateral line development. Zebrafish embryos at the 1-cell stage were
microinjected with either 1 nl of phenol red or CXCL14 antisense morpholino in phenol red
buffer. Microinjected embryos were then incubated at 24, 36, and 48 hpf and compared against
non-injected embryos. To determine the effects of microinjection on gene expression, RT-qPCR
was used to determine the mRNA levels of seven zebrafish genes during lateral line development
at 24, 36, and 48 hpf: CXCL12, CXCL14, CXCR4, CXCR7, snail-1b, cldn-2, and epcam. To
compare the effects of microinjection on gene expression, relative gene expression levels of
sham-injected embryos were compared to non-injected embryo mRNA levels at 24, 36, and 48
hpf (Figures 10, 11, and 12). The data were presented as Log2 mRNA levels of injected embryos
relative to non-injected embryos. To compare the effects of morpholino-injections on gene
expression, relative gene expression levels of morpholino-injected embryos were compared to
sham-injected embryo mRNA levels at 24, 36, and 48 hpf (Figures 13, 14, and 15). The data
were presented as Log2 mRNA levels of injected embryos relative to sham-injected embryos.

4.1. CXCL14 modulating the CXCL12-CXCR4 signaling pathway
Although the data were not all statistically significant, it can be noted that both sham- and
morpholino-injections influence gene expression. When comparing CXCL12 gene expression
between sham- and morpholino-injections, there is a distinct inverse relationship between the
two. After sham-injections, CXCL12 gene expression decreased by 2.17-fold at 24 hpf, followed
by 2.1-fold increase at 36 hpf (Figures 10 and 11) whereas after morpholino-injections CXCL12
gene expression increased by 12.6-fold at 24 hpf before decreasing by 1.8-fold at 36 hpf (Figures
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13 and 14). The inverse change in CXCL12 gene expression after CXCL14 knockdown indicates
that CXCL14 is modulating CXCL12 gene expression. These findings coincide with other
studies examining CXCL14 function relative to CXCL12 activity (Tanegashima and Hara, 2012;
Tanegashima et. al, 2013).
A similar trend is also observed with expression of CXCL12’s receptors: CXCR4 and
CXCR7. Following sham-injections, CXCR4 gene expression decreased by 1.2-fold at 24 hpf,
followed by a 1.8-fold increase at 36 hpf (Figures 10 and 11). Inversely, morpholino-injected
embryos had an increase in CXCR4 gene expression by 2.7-fold at 24 hpf, followed by a 1.08fold decrease in gene expression at 36 hpf (Figures 13 and 14). This relationship can also be seen
for CXCR7 gene expression. Following sham-injections, CXCR7 mRNA levels decreased by 4.6fold at 24 hpf before increasing by 10.1-fold at 36 hpf (Figures 10 and 11). Whereas after
CXCL14 morpholino-injections CXCR7 gene expression increased by 3.78-fold at 24 hpf, then
decreased by 25.6-fold at 36 hpf (Figures 13 and 14). As with CXCL12, this result suggests
CXCL14 play a role in modulating CXCR4 and CXCR7 mRNA levels. These findings coincide
with previous studies characterizing CXCR4 and CXCR7 as receptors for CXCL12
(Tanegashima and Hara, 2012; Tanegashima et. al, 2013).
Additionally, a notable trend is found between injections for CXCL14. Following shaminjections, CXCL14 increased gene expression by 15-fold at 24 hpf, followed by a 1.16-fold
decrease at 36 hpf and later a 3-fold increase at 48 hpf (Figures 10, 11, and 12). More notably,
these results have an inverse relationship with CXCL12 sham-injection results. This suggests the
idea that CXCL14 and CXCL12 gene expression modulate each other.
In addition to CXCL14 modulating CXCL12-CXCR4 and CXCR7 gene expression, we
have observed a significant change in snail-1b gene expression following CXCL14 knockdown.
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During sham-injections, snail-1b gene expression steadily increased between 24 hpf and 48 hpf
(Figures 10, 11, and 12). Following treatment with morpholino-injections, snail-1b gene
expression decreased by substantial amounts (Figures 13, 14, and 15). Snail 1-b is typically
found in the leading cells of the lateral line system during development. Our results suggest
CXCL14’s capability to impact lateral line development outside the CXCL12-CXCR4 signaling
pathway.
4.2. Future Research
This research project could be expanded in several different ways in order to inform our
understanding of the relationship between CXCL14 modulation of the CXCL12-CXCR4
signaling pathway and lateral line development. Future studies include a continuation of qPCR
trials. By running more qPCRs, we can definitively support our claim that CXCL14 is
modulating the CXCL12-CXCR4 signaling pathway. It will also be important to visualize
changes in gene expression in morpholino injected embryos. Through in-situ hybridization, we
can confirm qPCR results by visualizing increased or decreased gene expression of CXCL12,
CXCR4, and CXCR7 in the lateral line tissues. This is important because these genes may be
expressed in other tissues in the embryos, not just the lateral line system. In addition to in-situ
hybridization, we should examine the morphology of the neuromasts’ cells and sensory neuron
innervation in sham and morpholino injected embryos to determine if CXCL14 knockdown
affects the formation or innervation of neuromasts. Beyond morphological changes, functional
changes should be examined. For example, a flow-chamber assay may help provide deeper
insight on the functional changes occurring after CXCL14-knockdown. By allowing morpholinoinjected embryos to develop into further stages, we can assess their ability to orient themselves in
moving water. By analyzing their ability to swim in the event of any water-current stimuli, we
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can determine whether CXCL14 knockdown functionally affects lateral line development in
zebrafish.
In conclusion, our study has provided evidence supporting CXCL14 modulation of
CXCL12 gene expression. Additionally, we provide evidence that CXCL14 modulates both
CXCR4 and CXCR7 gene expression, thereby suggesting its ability to modulate the CXCL12CXCR4 signaling pathway more broadly. Based on our overall findings, we suggest that
CXCL14 may impact lateral line development. However, further work needs to be done to
understand the full extent of these relationships.
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APPENDIX
Appendix I: Zebrafish Husbandry
How to Add Water to the Fish System
* Make sure aged tap water is pre-warmed (28.5ºC) in bucket(s) in the Fish Room before
starting
1. Connect the input rubber tube to the output port on the filtration pump (Pentair- Aquatic
Habitats, Minneapolis, MN, USA)
2. Connect one end of the intake tube to the input port on the filtration pump
a. The other end of the intake tube goes into the bucket with pre-warmed aged tap
water
3. Lift the clear plastic cover of the “sump” from the fish system (Aquaneering, San Diego,
CA, USA) to check water levels
4. Turn on the pump and add water until water level reaches the bottom of the white
horizontal drain tube in the “sump” area of the fish system
5. Turn off the pump, remove input and output tubes, and replace the clear plastic cover of
the sump
6. Refill water buckets with water from the stainless-steel tanks in the aquarium room so
there will be pre-warmed water for the next day

Shurflo

Input tube

Pump
Intake tube

Pre-warmed
water

1

How to Clean Tanks
1. Lift the tank and allow water to flow down the drain tube
2. Place the tank on the counter near the sink
Replace with a new tank
a. Insert the green baffle and fill the new tank with water from the
water supply
b. Use a net to gather fish and place them inside the fresh, clean
tank
i. Place the tank in the corresponding spot- ensure
zebrafish birthdates and tank number are displayed on
the front of the tank
Water supply
c. Ensure the “hose” is in the second hole of the lid
feeder
d. Place the funnel in the first hole of the lid
e. Place the food feeder above the funnel and screw
tightly
i. Ensure the feeder is aligned with the funnel so
that the food falls through the funnel and into
the tank
3. Dump the water from the dirty tank down the drain
4. Rinse the tank with tap water
a. Pour bleach into the tank
i. Enough to barely fill the bottom of the tank
1 mL of bleach for every 50 mL of H2O
5. Fill the tank with water
a. Careful not to fill the tank all the way since it needs to be moved from the counter
and onto the shelf
i. DO NOT SPILL THIS WATER INTO ANY OF THE BUCKETS
6. Carefully place the tank on the back of the bottom shelf
7. Fill the rest of the tank with water using a plastic cup
a. You want the bleach to reach the overhang
i. The tank is in the far back so that the bleach water from the overhang can
run down the back of the wall and into the drain
8. Rinse the lid and baffle with dI water and place it in the tank
9. Allow the tank to be submerged in bleach water for at least 24 hours
10. After the 24 hours have passed, rinse the tank and its parts with tap water, then rinse them
with dI water at least 3 times
11. Leave items on the shelf to air dry

2

Appendix II: Preparing Solutions
How to make 1x Danieau solution
1. Gather reagents to make 1x Danieau solution
Stock
Concentration

Concentration needed

5M

58 mM NaCl

3M

0.7 mM KCl

100 mM

0.4 mM MgSO4

100 mM

0.6 mM Ca (NO3)2

0.5 M

5 mM HEPES pH 7.6

2. Calculate the amounts of reagents needed to make 5 mL of 1x Danieau solution
1 M= 1000 mM
1 mL= 1000 ul
Stock [concentration] x stock volume = Final [concentration] x final volume (5 mL)
•

NaCl
5000 mM (x) = 58 mM (5 mL) → x= (290 mM/mL)/5000 mM → 0.058 mL or 58 ul

•

KCl
3000 mM (x) = 0.7 mM (5 mL) → x= (3.5 mM/mL)/ 3000 mM → 0.0011 mL or 1.166 ul

or 11.66 ul from a 1:10 dilution
•

MgSO4
100 mM (x) = 0.4 mM (5 mL) → x= (2 mM/mL)/ 100 mM → 0.02 mL → 20 ul

•

Ca (NO3)2
100 mM (x) = 0.6 mM (5 mL) → x= (3 mM/mL)/ 100 mM → 0.03 mL → 30 ul

•

HEPES
500 mM (x) = 5 mM (5 mL) → x= (25 mM/mL)/ 500 mM → 0.05 mL → 50 ul
Total: 169.66 ul

•

Milli Q water
5 mL → 5000 ul- 169.66 ul reagents = 4830.34 ul Milli Q
3

How to Resuspend Morpholino
1. Find morpholino (Gene Tools, LLC., Philomath, OR, USA)
a. Stock solution of SCYBA 2: 300 nmol freeze dried
b. Sequence: 5’- CCGTACTACAGCGATTCATCCCCAA-3’
2. Resuspend morpholino in 250 ul of 1x Danieau solution
a. DO NOT VORTEX OR SHAKE VIAL
i. Swirl the solution by slowing turning the vial around the sides, then up
and down
1. This ensures that the 1x Danieau solution reaches the freeze-dried
powder on the cap and around the vial
3. Parafilm the morpholino vial and let it sit in the fridge for roughly 30 minutes
4. Aliquot the morpholino and label. Store stock solution and aliquots in “Scyba MO box”
in -20 ºC
Number of
Aliquots

Amount

1

100 ul aliquot (remains in vial)

1

50 ul aliquot

1

25 ul aliquot

15

5 ul aliquot

5. When microinjecting morpholino, make sure it is 1 nL in volume
a. Between two lines in width (0.2 mm in width)

Morpholino Troubleshooting Guide
1. Accidentally pipetted 1,100 ul of Danieau solution, making morpholino 4x too dilute
a. Decided to lyophilize morpholino
i. Placed morpholino in -80 ºC freezer
ii. When frozen, put morpholino on counter and parafilm it
1. Poke 5 little holes in the parafilm then place cap on vial
iii. Place vial in lyophilizing container
1. Cushion vial with paper towels
iv. Turn lyophilizing machine on and set temperature to -80 ºC
v. Add the lyophilizing container (with the cap on) and attach it to the tube
vi. Leave on overnight
*Vial now contains morpholino and salts from Danieau solution. Resuspend morpholino
with 250 ul Milli Q H2O and follow “How to Make Resuspend Morpholino” protocol
4

1.
2.
3.

4.
5.

How to make 1x E3 Buffer for Standard work with Embryos
Find 50x E3 buffer in 4 ºC fridge
Rinse 1x E3 bottle with dI H2O
Calculate the amount of 50x E3 needed to make 1000 mL of 1x E3 buffer
Stock
Final
(50x E3) (x) = (1x) (1000 mL)
x = (1000x/ mL)/ 50x
x = 20 mL
Add 20 mL of 50x E3 buffer to 980 mL of dI H2O to make 1L (1000 mL) of 1x E3
Store 1x E3 buffer in Fish Room for embryo isolation and in lab for embryo maintenance

*Key points: E3 can be made up as a 60x stock. The 1x medium keeps under non-sterile
conditions at room temperature for over a week. 60x E3 stock contains methylene blue. When
zebrafish embryos are kept in 1x E3 buffer, they contain the methylene blue reagent, which
suppresses fungal outbreaks in Petri dishes in the event that an egg goes bad.
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Appendix III: Embryo Isolation and Injection
How to Set-Up Mating
1. Select a tank (Aquaneering, San Diego, CA, USA) between 2:00 pm – 4:00 pm
a. This allows for adequate hormone build up
b. Follow the order on the “Tank Mating List” in the Fish Room
i. Fish will need a 3-5 day rest period before another mating can be set up
2. Retrieve the tank
a. Remove the automatic feeder (Penn Plax Inc., Memphis, TN, USA)
i. Unscrew the light blue knob and remove the feeder
b. Turn off the water supply for that tank. Lift the tank by the
front side
i. This lowers the water level which prevents a mess
from happening when you take the tank out
c. Remove the tank
i. Lift the tank up and over the drain pipe
d. Place the tank on the counter near the sink
2
3. Set up the Mating Tank
a. Grab the two mating tank components (Pentair- Aquatic
Habitats, Minneapolis, MN, USA)
1
i. Clear, plastic tank (#1)
ii. Clear, plastic tank with holes on the bottom (#2)
b. Insert the 2nd container into the first
i. This allows the fish to lay eggs that can be
collected easily. The eggs will sink to the
bottom, passing through the holes at the bottom
of container #2, and kept isolated in container
#1.
c. Fill the mating tank with water from the main tank set up (filtered aged tap water)
4. Transfer fish to the mating tank
a. Using a small black net, capture the fish and transfer them
to the mating tank
b. Using a divider, separate the fish by sex (male or female)
c. Place a lid on top of the tank and put them on the shelf.
Male Female
i. If mating more than one tank, label it with the number
corresponding to the tank (#1-6)
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Figure 1: Distinct characteristics between Male and Female Zebrafish

5. Clean up
a. Rinse the net with dI H2O before returning
b. If the original tank is clean, return it to its designated area and turn H2O back on
c. If the original tank is dirty, following “How to Clean Tanks” protocol
d. Feed fish after separating them in mating chamber or around 8:00 pm
6. Pull the divider at 9:00 am and isolate embryos- see “How to Microinject Embryos”
* If they do not lay at or around 9:30 am, check “Embryo Collection Troubleshooting
Guide”
** Significant changes
• Fish were cycled as they aged
o A few days into the project (June 2018), 12 zebrafish were brought into
our facility. Following a 2-3 weeks acclimation period, zebrafish were
used for mating purposes. The 12 zebrafish were separated into two tanks:
three males and three females in each tank
o Fish over a year old were euthanized and replaced with newer fish
o Four months into the project (October 2018), 6 zebrafish (3 males and 3
females) were brought into our facility. Following a 2-3 weeks
acclimation period, zebrafish were used for mating purposes.
• There are currently only four tanks
o Each tank contains three males and three females
• Nine months into the project, the light-dark cycle changed from “9:30 am- 11:30
pm” to “9:00am- 11:00 pm”
• Ten months into the project, the light-dark cycle changed from being dial
operated to analog operated
o This ensures better accuracy of light-dark cycle

7

Embryo Collection Troubleshooting Guide
1. Pull divider at 9:00 am
2. Check for embryos at 9:30 am
a. If there are embryos, follow protocol
b. If there aren’t any embryos, check again in 30 minutes
3. Check for embryos at 10:00 am
a. If there are embryos, follow protocol
b. If there aren’t any embryos, check again in 30 minutes
4. Check for embryos at 10:30 am
a. If there are embryos, follow protocol
b. If there aren’t any embryos, check again in 30 minutes
5. Check for embryos at 11:00
a. If there are embryos, follow protocol
b. If there aren’t any embryos, check again in 30 minutes
6. Check for embryos at 11:30 am
a. If there are embryos, follow protocol
b. If there aren’t any embryos, check again in 30 minutes
7. Check for embryos at 12:00 pm
a. If there are embryos, follow protocol
b. If there aren’t any embryos, return zebrafish to original tank and rinse mating
chamber with dI H2O
i. Record “no” under “embryos?” in the “Tank mating sheet” kept in the
Fish Room
8. Check to see if food funnels are clogged
9. Check if automatic feeders are adequately filled with food
10. Check if feeders are aligned to funnels
11. Ensure tanks are clean and the “sump” is adequately filled
a. For instructions, please see “How to Clean Tanks” and “How to Add Water to the
Fish System”

Sump
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How to Microinject Embryos
1. Pulling and loading needles- See Figure 2
a. Take a Borosil 1.0 MM OD x 0.5 MM ID capillary tube (FHC Inc., Bowdoin,
ME, USA)
b. Insert the capillary tube into the grooves of the Heka Pipette Puller (Heka
Instruments, Bellmore, NY, USA)
i. Go as far down the groove as it can go without dropping it
c. Tighten the first yellow bar
d. Lift the second yellow bar to spacer disk setting 12
i. Tighten the second yellow bar and remove spacer disk
e. Flip switch to “A,” turn power on, and hit START
i. Red coil appears when heating then cools back down
f. Flip switch to “off,” loosen the first yellow bar and lift it to spacer disk setting 5
i. Tighten the yellow bar and remove spacer disk
g. Flip switch to “B” and hit START
i. The coil will turn red when heating, then cool down
h. Loosen the first yellow bar
i. Remove top pipette
1. Dispose of this pipette in “sharps” box
i. Loosen the bottom yellow bar while holding onto the pipette
i. Carefully remove the pipette
1. THIS NEEDLE WILL BE USED FOR MICROINJECTING
EMBRYOS
j. Place newly made pipette on clay (let it hang from the shelf) until ready to load
i. When you are ready, use a P2 pipette to pipette 1.5 ul of what you will
inject into the embryos
1. For Morpholino, follow Step #2
2. For Sham injection (phenol red), follow Step #3
2. Preparing Morpholino injections
a. Go to freezer (-20°C) and find “Scyba MO” box (3rd shelf)
b. Pick a 5 ul aliquot of Morpholino (Gene Tools LLC., Philomath, OR, USA) and
put box back in the freezer
c. Add 5 ul of phenol red injection buffer (Sigma-Aldrich, St. Louis, MO, USA) to
the morpholino aliquot to make the final volume 10 ul
d. Quick spin in centrifuge (SciLogex LLC, Rocky Hill, CT, USA)
e. Load the pipette that was made in the pipette puller with 1.5 ul of Morpholino
i. Let the Morpholino reach the tip of the needle
f. Cover Eppendorf cap with parafilm and store the MO solution in the 4°C fridge
i. This is to prevent evaporation
*For information on morpholino, see “How to Resuspend Morpholino”
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3. Preparing Sham injections
a. Add 5 ul of 1x Danieau solution to 5 ul of phenol red (1:1 ratio)
*This is a troubleshooting attempt to prevent high levels of embryo mortality
i. Originally, you would only use phenol red as the injection buffer. This
resulted in high levels of embryo mortality. Since morpholino is
resuspended in 1x Danieau solution, we decided to mix equal parts of
phenol red with equal parts of 1x Danieau solution.
ii. For instructions, see “How to make 1x Danieau solution”
4. Microinjection Set-up- See Figures 2 and 3
a. Turn on Fiber-Lite High Intensity Illuminator Series 180 (Dolan-Jenner
Industries, Boxborough, MA, USA)
i. Keep intensity at “4”
ii. This is the microscope light
b. Turn on Leitz AC volts light source (E. Leitz Inc., New York, NY, USA)
c. Turn on Picospritzer III (Parker Hannifin Corporation, Pine Brook, NJ, USA)
i. Turn switch to “MSEC”
1. This is milliseconds
ii. This controls the duration at which microinjection occurs
d. Turn on gas tank (Airgas Inc., Radnor, PA, USA)
i. This allows air to pass through the pipette for microinjection
e. Carefully insert the pipette from Step 1 into the micromanipulator (Narishige
International Inc., Amityville, NY, USA)
i. Make sure it is loaded- either Step 2 or 3
5. Mineral Oil Test
a. Once the pipette is inserted into the micromanipulator, run the very tip of the
needle against a small pumice stone
*This is a change that results in a more controlled break of the tip. Before,
you would use a pair of forceps to make a small break at the tip of the
needle. By using a pumice stone, you simply run it against the stone softly.
b. Use a P2 pipette tip to “scoop” a large drop of mineral oil
c. Add the drop of mineral oil onto the middle of the black circle in the mineral oil
slide.
i. The mineral oil slide is kept in a small black case in the drawer labelled
“Microinjection supplies”
d. Bring the micromanipulator close to the microscope so that the needle is in the
mineral oil
i. Adjust as necessary
e. Step on the foot pedal (located under the bench). Air will pump through the
needle and onto the mineral oil slide
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i. Depending on how big your bubble is, decide if the pipette is fine or needs
to be broken a bit more
ii. Worst case scenario, your needle breaks more than you anticipated and
you will need to start the process over
iii. Ideally, you want the bubble to be between 2 spaces in width (2 spaces in
width= 1 ng/nl)
0.1 mm= 0.5 nl, so 0.2 mm= 1 nl
f. Once you have your ideal needle, bring the embryos and store mineral oil slide in
drawer labelled “Microinjection supplies”
i. Clean off the mineral oil that is on the slide with a kimwipe (Kimtech Inc.,
Vaughan, Ontario, CA) and put it back in its case
6. Isolating Embryos
a. Pull the mating tank from the shelf and place it on the counter
b. Fill a separate mating chamber (just the container without holes at the bottom)
with filtered aged tap water. Place this mating chamber on the counter near the
sink
c. Lift the container with holes in the bottom and transfer it to a new mating
chamber
i. This allows you to continue collecting embryos in case the zebrafish are
not done laying
d. Grab the fine strainer and hold it over the sink
e. Pour water from the mating tank through the strainer and into the sink
i. Since you are using a fine strainer, the embryos are just big enough to not
flow though.
ii. Since some debris will stick around, use a squirt bottle to remove feces,
debris, etc. from the strainer
1. The squirt bottle should always be filled with 1x E3 buffer and
kept in the fish room
a. For instructions, please see “How to Make 1x E3 Buffer”
f. Once there are only embryos in the strainer, grab a 100 x 15 mm petri dish (VWR
International, Radnor, PA, USA) and add some 1x E3 buffer to the dish
g. Flip the strainer over the dish. Using the squirt bottle to push the embryos from
the strainer onto the dish
i. The force of the squirt is enough to push the embryos off the strainer and
into the petri dish
h. Cover the petri dish with a lid and label (AC, date, time, tank #)
i. Record “Yes” under “embryos?” for corresponding tank number on the sheet
j. Place the mating chamber back on the shelf
i. Zebrafish typically lay every 20-30 minutes for a set period of time
1. If not, please see “Embryo Isolation Troubleshooting Guide”
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k. Microinject embryos 30 minutes after laying to ensure proper injection
7. Injecting Embryos- See Figure 4
a. Grab a P1000 and a P1000 pipette tip
i. Cut the end of the pipette tip to make the opening larger
b. In a drawer labelled “Microinjection supplies,” grab a petri dish and put a normal
slide inside
c. Using the P1000, pipette embryos onto the petri dish along the edge of the slide
i. Tilt the dish to the side so water flows through the slide, leaving embryos
aligned along the straight edge
1. Remove water as necessary
d. Once all the embryos are aligned, place the petri dish under the microscope and
bring the micromanipulator (with the loaded pipette) to the microscope and dish
e. Use the microscope to adjust the needle so it can puncture the embryo at the right
spot in the yolk- see Figure 4
i. Careful to adjust the needle as much as possible before puncturing the
embryo. If you adjust the needle while it is in the embryo, you will cause
significant damage. Align it to where the needle will puncture into the
yolk, not just the chorion itself
f. Hit the foot pedal and air will pump through the pipette to inject the embryo
i. To see if the embryo is injected, look in the microscope. Embryos should
have a spot of pink-red hue inside
g. Go down the line of embryos by moving the dish to and from the pipette and
inject all the embryos
h. Once all the embryos are injected, use forceps to lift the slide off the dish
i. Begin by lifting the corner of the slide. Once the slide is upright, hold it
steady with your fingers and lift up
ii. Be careful not to damage any embryos in the process. To avoid this, do not
drop the slide after it is in an upright position.
iii. If any embryos are stuck to the slide, use a squirt bottle with 1x E3 buffer
to push them back onto the dish.
i. Fill the petri dish with 1x E3 buffer and put a lid on it. Label the lid (AC, date,
time, # of embryos, type of injection, incubation period)
j. Keep the petri dish in the 28°C incubator (Benchmark Scientific Inc., Sayreville,
NJ, USA)
k. Repeat this process for every batch of embryos you get. Be sure to isolate and
inject embryos 20-30 minutes after they have been laid.
i. This is to ensure embryos are injected at the 1-cell stage
8. Turn it off
a. Turn off Fiber-Lite High Intensity Illuminator and Leitz AC volts light sources
b. Flip switch to “MIN” in PICOSPRITZER III
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c. Turn off Airgas
d. Discard needle into “sharps” box
e. Hit the foot pedal. The gas should release for 1 minute
i. Gas valves should go down to zero
f. Turn off PICOSPRITZER III and flip switch back to “MSEC”
9. Make sure zebrafish are put back into the original tank
a. Turn the water for the original tank off. Place the tank on the counter. Remove the
lid.
b. Lift the mating tank (with holes on the bottom) and align it to the original tank
c. Tilt the mating tank so that the fish can go back in the tank
d. Place the lid back on the original tank and return it to its designated area
e. Turn the water supply back on, place the food funnel in the designated area and
align the automatic fish feeder above the funnel
i. Ensure that the feeder is full of food and aligned properly
10. Rinse and air dry
a. Rinse mating tanks (both containers) and strainer with dI H2O. Allow them to air
dry on rack
11. Periodically check on embryos
a. Ensure they have fresh 1x E3 buffer
b. Remove any unviable embryos
c. Remove any hyphae growing and replace buffer with fresh 1x E3 buffer.

13

Figure 2: Pulling Pipettes
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Figure 3: Microinjection Station
Gas supply
Microscope

Pipette puller
Pressure Systems for
Ejection of Picoliter Volumes
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microinjection needle
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Figure 4: Microinjecting Embryos
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Figure 4. Microinjecting Embryos. (A) Align embryos along the edge of a microscope slide
inside a petri dish. (B) Adjust the microinjection needle to where it can puncture the embryo at
the right spot inside the yolk. (C) Microinject embryos at the one-cell stage (30 minutes postfertilization) inside the yolk by the cell.
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Appendix IV. Molecular Techniques
RNAse-Free Zone
1. Obtain a 1500 mL flask and dilute 10 M NaOH into 0.2 M concentration
a. M1V1= M2V2
i. (1400 mL) (0.2 M) = (10 M) (?)
ii. 280 M/mL = (10 M) (?) → (280/10 M)
iii. V2= 28 mL
2. Use a pipette gun and 10 mL “baked for RNA work” pipettes to pipette 28 mL of 10 M
NaOH into the empty flask.
a. Discard pipette in 2% bacdown 5/24 pipette jar
3. Add 1372 mL deionized H2O into the flask and swirl
4. Pour solution into a 1500 mL beaker
5. Take pipettes apart
a. Let pipette barrels soak in 0.2 M NaOH for ~1 hour
6. Obtain 1000 mL of 95% EtOH
7. After ~1 hour of pipette barrels soaking in 0.2 M NaOH, pour 0.2 M NaOH solution into
the original 1500 mL flask. Label (0.2 M NaOH + dI H2O AC 6/14)
8. Rinse beaker and pipette barrels with Milli Q H2O
9. Transfer 1000 mL EtOH from the flask into the beaker
a. Let pipette barrels soak in 95% EtOH for ~30 minutes
10. After soaking in 95% EtOH for ~30 minutes, rinse pipette barrels with Milli Q H2O and
leave to air dry in RNAse-free zone
11. Transfer 95% EtOH from beaker into the original flask and label (95% EtOH AC 6/14)
12. Rinse beaker with Milli Q H2O and leave to air dry
13. Wipe down RNAse-free area thoroughly
a. Wipe pipette parts, boxes of pipette tips, bottles with solutions, tubes with
solutions, gel box, gel tray, gel comb, lab bench, etc… with 0.2 M NaOH
b. Following 0.2 M NaOH treatment, wipe items and bench space with 95% EtOH
and leave them to air dry
*Key Points: NaOH degrades RNases, 95% EtOH gets rid of base and sterilizes everything
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RNA Isolation
RNA isolation prepared using the Direct-zol RNA Mini Prep kit (Zymo Research, Irvine, CA,
USA) in an RNAse-free station with aerosol-resistant pipette tips
** All centrifugation steps are done at 10,000-16,000 x g for 30 seconds
1. Add ethanol to buffers (this step only needs to be done once)
a. Add 10 mL of 95-100% EtOH to “Direct-zol RNA Pre-Wash
b. Add 48 mL of 100% EtOH to “Direct-zol RNA Wash Buffer”
i. Use the pipette gun and a 10 mL baked pipette to add 100% ethanol
1. Discard pipette in 2% bacdown pipette jar
2. Check embryos under microscope
a. Discard any ruptured, unfertilized, or unviable embryos. Ensure proper incubation
period is achieved before proceeding
3. Lyse and homogenize embryos in appropriate volume of TRI Reagent
a. For cells  106, add 250 ul TRI Reagent
i. 50 embryos are needed per incubation period within each time point
(Peterson and Freeman, 2009)
1. If there are less than 50, preserve them using dry ice and ethanol.
For instructions, see “RNA Isolation Troubleshooting Guide”
ii. Homogenize embryos with baked RNAse-free homogenizers
4. Centrifuge sample to remove particulate debris and transfer the supernatant into a new,
RNAse-free Eppendorf tube
5. Add an equal volume of 95-100% ethanol to the supernatant (250 ul) and mix thoroughly
6. Transfer solution into a Zymo-Spin IIC Column in a collection tube and centrifuge
a. Discard flow through
7. DNAse I Treatment
a. Add 400 ul of RNA Wash Buffer to the column and centrifuge
i. Discard flow through
b. In RNAse-free Eppendorf tube, add 5 ul of DNAse I and 75 ul of DNA Digestion
Buffer. Mix thoroughly
i. Add the mix directly to the column matrix. Careful not to puncture column
c. Incubate at room temperature for 15 minutes
8. Following the incubation period, add 400 ul of Direct-zol RNA Pre-Wash to the column
and centrifuge
a. Discard flow through
9. REPEAT STEP #8
10. Add 700 ul of RNA Wash Buffer to the column and centrifuge for 2 minutes to ensure
complete removal of the wash buffer
11. Transfer column into an RNAse-free tube. Label (AC RNA #, date, type of injection)
12. To elute RNA, add 100 ul DNAse/RNAse-free H2O to the column matrix and centrifuge
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13. Record RNA concentration and purity using the NanoDrop (Thermo Fisher Scientific,
Waltham, MA, USA)
a. For list of RNA concentrations, please see “How to use the NanoDrop”
14. Store RNA in -80°C freezer, Room #312
a. Stored in “Section 3, Row 2” in the box labelled “Ariana Embryo Work”
15. Once you have RNA isolated from every time point and injection, run an RNA gel
a. By loading RNA into a gel, we can visualize and compare the size of the bands to
the concentration values from the Nanodrop. This is also used as a quality control
method to determine whether RNA is degraded or not.
i. For instructions, please see “Gel Electrophoresis”
RNA Isolation Troubleshooting Guide
1. Based off the literature, 50 zebrafish embryos are needed for RNA isolation (Peterson and
Freeman, 2009)
2. If there are not enough viable embryos to fulfill this requirement, freeze embryos with dry ice
and store in -80°C freezer
a. After several attempts, it can be concluded that the appropriate amount of ethanol
should be added in before flash freezing embryos with dry ice.
3. DO NOT FLASH-FREEZE EMBRYOS IN TRIZOL.
a. This resulted in low RNA concentration
250 ul Trizol or Ethanol/ 50 embryos= 5 ul of Trizol or Ethanol per embryo

1.

2.
3.
4.

5.
6.

7.

How to Bake Homogenizers
Select three glass homogenizers
a. Assign one homogenizer for each type of injection: non-injected, sham injected,
and morpholino injected
Rinse with soap and dI H2O after each use
Allow homogenizers to air dry
Once dry, wrap homogenizers and respective pestles in aluminum foil
a. To denote “morpholino-injected” pestle and homogenizer, color the end of the
aluminum foil with a red sharpie
Place the pestles and homogenizers (wrapped in aluminum) in the oven (Blue M Electric,
Blue Island, IL, USA) located in the stockroom
Set time for 6.5 hours to allow for proper elimination of DNA nucleases
a. It takes ~1 hour to reach the temperature necessary to get rid of nucleases. The
oven needs 4 hours to bake. This method is used for dry, hot sterilization
Handle with gloves and keep in an RNAse-free station
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How to use the Nanodrop
1. Take an RNAse-free pipette and P2 aerosol-resistant pipette tips. Keep RNA on ice.
Wear gloves at all times
a. Go to room #330A to use the NanoDrop (Thermo Fisher Scientific, Waltham, MA,
USA)

2. Go to the computer, click “start” and select “NanoDrop 2000”
3. You will be taken to the NanoDrop homepage. For RNA analysis, click “Nucleic Acid”
4. On the right-hand side of the screen is “type.” Click it and find “RNA.” Choose this
option
5. For “sample ID,” type “Milli Q” and load the blank solution
a. Pipette 1 ul RNAse-free Milli Q on the nanodrop platform
b. Lower the arm pedestal
6. Click on “blank”
a. Now that the NanoDrop is cleaned and blanked, lift the arm pedestal and wipe the
upper (arm) and lower (platform) pedestal with a kimwipe
b. Be sure to clean the pedestal with a clean kimwipe after each sample is measured,
even if it is just Milli Q.
7. For safe measure, load 1 ul of Milli Q H2O and measure
8. Clean pedestal and load 1 ul of RNA sample
a. Type “RNA #, date, type of injection” for “sample ID”
b. Pull down the arm and click on the “measure” button
9. Lift the arm up, wipe the pedestal, and load 1 ul of Milli Q H2O
a. Pull the arm down and click on the “measure” button
10. Clean the pedestal and repeat steps #7-9 until all RNA samples are measured. If there are
no more RNA samples left to measure, end the process by loading 1 ul of Milli Q H2O
and wiping the pedestal
11. Record and save data
a. To save the data, go to “Report” and highlight the samples you want to save
b. Click on the “export” button
c. Where it says “My Documents,” click the drop down arrow and select “Nanodrop
data”
d. Create a new folder (Ariana- Wall RNA)
e. For “filename,” type “RNA #, Date, Type of injection”
f. For “save as,” select “Spectra New Workbook (*.twbk) and click “save”
g. Close out of the program and store RNA in the -80°C freezer
*Key points: The NanoDrop is used to measure RNA concentration and purity. Ideally, an RNA
A260/280 ratio around 1.8-2.0 indicates pure RNA. By having RNA concentrations (ng/ul), we
can calculate how much RNA to use for cDNA synthesis. This ensures an equal amount of RNA
is pipetted into each tube for cDNA synthesis.
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RNA Batch #1
Date

Type of
Injection

Time Point

RNA #

7/5

Sham

24 hr

1

155.1 ng/ul

2.04

7/19

Non

36 hr

2

274.7 ng/ul

2.02

7/23

Morpholino

24 hr

4

136.3 ng/ul

2.06

7/23

Morpholino

36 hr

5

151.6 ng/ul

2.05

7/24

Sham

36 hr

6

90.2 ng/ul

2.10

7/25

Non

24 hr

3

188.8 ng/ul

2.05

7/31

Sham

36 hr

6

153.7 ng/ul

2.02

10/1

Non

48 hr

7

69.0 ng/ul

2.06

10/1

Sham

48 hr

8

337.6 ng/ul

2.00

10/1

Morpholino

48 hr

9

9.8 ng/ul

2.09

10/16

Non

48 hr

7

145.6 ng/ul

2.04

10/16

Morpholino

48 hr

9

145.8 ng/ul

2.01

*Added 48-hour time point in October 2018
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Nucleic acid
A260/280
concentration

RNA Batch #2
Date

Type of
Injection

Time Point

RNA #

Nucleic acid
A260/280
concentration

1/14

Non

24 hr

3

150.5 ng/ul

2.03

1/14

Morpholino

24 hr

4

109.0 ng/ul

2.05

1/14

Sham

48 hr

8

142.8 ng/ul

1.99

1/15

Non

36 hr

2

245.2 ng/ul

2.03

1/15

Morpholino

36 hr

5

162.3 ng/ul

2.01

1/15

Non

48 hr

7a

278.7 ng/ul

1.99

1/15

Non

48 hr

7b

205.7 ng/ul

1.99

1/15

Non

48 hr

7c

212.8 ng/ul

1.98

1/15

Non

48 hr

7d

295.1 ng/ul

1.94

1/13

Sham

24 hr

1

163.4 ng/ul

1.99

2/11

Sham

36 hr

6

236.2 ng/ul

2.01

2/11

Morpholino

48 hr

9

193.7 ng/ul

2.00

RNA Batch #3
Date

Type of
Injection

Time
Point

RNA #

Nucleic acid
A260/280
concentration

2/11

Non

36 hr

2

274.0 ng/ul

2.00

3/30

Non

24 hr

3

284.3 ng/ul

2.00

3/30

Sham

24 hr

1

270.0 ng/ul

2.03

3/30

Morpholino

24 hr

4

205.7 ng/ul

2.05
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cDNA Synthesis
*Synthesize cDNA in an RNAse-free environment. Use aerosol resistant barrier pipette tips
1. Calculate the amount of RNA (ul) needed for the cDNA synthesis reaction
a. Calculations
Volume for cDNA synthesis (x ul) * [sample] = 1500 ng (1.5 ug)
i. Plug in RNA concentration value in [sample]. Divide 1500 ng by RNA
concentration to solve for “x” (volume needed for cDNA synthesis in ul)
b. From there, calculate the amount of RNAse-free H2O needed to bring the reaction
total up to 12.5 ul.
12.5 ul reaction – calculated RNA volume (ul) = x ul RNAse-free H2O
c. Repeat calculations for each time point within each injection type
Component

Final
Concentration

Volume- 1x
MM

9.5x MM

Oligo dT (10 uM)

0.5 uM

1 ul

9.5 ul

dNTP (10 mM)

500 uM

1 ul

9.5 ul

1x

4 ul

38 ul

RNasin (40 U/ul)

20 U/rxn

0.5 ul

4.75 ul

Easy Script RTase (200 U/ul)

200 U/rxn

1 ul

9.5 ul

---

x ul

x ul

0.5-5 ug/rxn

x ul

x ul

5x RT Buffer

RNAse-free H2O
RNA

Total: 20 ul cDNA mix
2. Retrieve RNA from -80ºC freezer
3. Thaw RNA and cDNA synthesis reagents (Lamda Biotech Corporation, Ballwin, MO, USA)
on ice
a. Oligo dT
b. dNTP
c. 5x RT Buffer
d. RNasin
e. Easy Script RTase
f. RNAse-free H2O
4. Mix each solution by vortexing for 10 seconds
5. Briefly centrifuge to collect residual liquid from the sides of the tubes
6. Prepare reaction mixture on ice in PCR tubes
7. Prepare a 9.5 master mix (MM) of solutions (excluding RNA and RNAse-free H2O)
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a. This step has been revised. Adapt master mix needs based off how many samples
there are. For the total number of cDNA reactions you plan to run, add an extra
0.5 “reaction.” This ensures there will be enough reagents in the master mix for
every reaction. This is because there is always a window of error that can occur
when using pipettes.
8. Pipette 7.5 ul of 9.5 MM into each PCR tube
9. Label PCR tubes “3, 1, 4, 2, 6, 5, 7, 8, 9” to dictate which RNA sample corresponds with
which PCR tube
10. Pipette RNA and RNAse-free water to the corresponding tubes (match calculated volumes to
RNA number on PCR tubes)

RNA # (Injection)

Batch #1
Volume (ul)

RNAse-free H2O (ul)

RNA 3 (Non 24)

7.944 ul

4.556 ul

RNA 1 (Sham 24)

9.671 ul

2.829 ul

RNA 4 (MO 24)

11.005 ul

1.495 ul

RNA 2 (Non 36)

5.460 ul

7.04 ul

RNA 6 (Sham 36)

9.759 ul

2.741 ul

RNA 5 (MO 36)

9.894 ul

2.606 ul

RNA 7 (Non 48)

10.30 ul

2.2 ul

RNA 8 (Sham 48)

4.44 ul

8.06 ul

RNA 9 (MO 48)

10.28 ul

2.22l
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Batch #2

RNA # (Injection)

Volume (ul)

RNAse-free H2O (ul)

RNA 3 (Non 24)

9.966 ul

2.534 ul

RNA 1 (Sham 24)

9.179 ul

3.321 ul

RNA 4 (MO 24)

13.76 ul

0 ul

RNA 2 (Non 36)

6.117 ul

6.383 ul

RNA 6 (Sham 36)

6.35 ul

6.15 ul

RNA 5 (MO 36)

9.24 ul

3.26 ul

RNA 7a (Non 48)

5.382 ul

7.118 ul

RNA 7b (Non 48)

7.29 ul

5.21 ul

RNA 7c (Non 48)

7.048 ul

5.452 ul

RNA 7d (Non 48)

5.083 ul

7.417 ul

RNA 8 (Sham 48)

10.504 ul

1.996 ul

RNA 9 (MO 48)

7.744 ul

4.756 ul

Batch #3
RNA # (Injection)

Volume (ul)

RNAse-free H2O

RNA 3 (Non 24)

5.276 ul

7.224 ul

RNA 1 (Sham 24)

5.555 ul

6.945 ul

RNA 4 (MO 24)

7.292 ul

5.208 ul

RNA 2 (Non 36)

5.474 ul

7.026 ul
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11. Set up the Thermocycler (Eppendorf AG, Hamburg, DEU)
a. User: Nancy
i. Hit “enter” when prompted for password
b. Find folder labelled “Nancy”
i. Add a new folder
1. Set up cDNA reaction- labelled “cDNA AC”
a. 42ºC for 60 minutes
i. This will be the incubation period
b. 85ºC for 5 minutes
i. This will be to stop the reaction
c. Chill at -20ºC
i. This is to preserve reactions until it can be stored in
the -20ºC freezer
12. Run cDNA synthesis
a. Find folder labelled “Nancy”
i. Select “cDNA AC”
b. Check thermocycler settings
i. Incubate at 42ºC for 60 minutes
ii. Heat reaction at 85ºC for 5 minutes
iii. Chill on ice
c. Hit “start”
13. Store until ready for use
a. Store in freezer at -20ºC until ready to run qPCR
b. cDNA reactions stored in “Ariana box of primers”
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Primer Design
Set #1: We read through the literature and identified possible genes in zebrafish that are affected
by, or downstream of, either CXCL14 or CXCL12.

Primer Design Set #1
Gene

Description

Control

B-actin 1: Beta-actin 1

reference gene control

Control

GAPDH: Glyceraldehyde 3phosphate dehydrogenase

reference gene control

DT of
CXCL14

NF-kB
(Nuclear factor kappa B p105)
SCX-a
(Scleraxis bHLH transcription factor a)

DT of
CXCL12

CXCL14 up-regulates activation of NF-κB
CXCL14 overexpression in chick embryo
fibroblasts upregulates connective tissue gene
expression

Pmp-22b
(Peripheral Myelin Protein 22b)

CXCL14 modulates expression myelin genes in
Schwann cells, alters cell proliferation

Mpz
(Myelin Protein Zero)

CXCL14 modulates expression myelin genes in
Schwann cells, alters cell proliferation

Mbp-a
(Myelin Basic Protein a)

CXCL14 modulates expression myelin genes in
Schwann cells, alters cell proliferation

OSR1
(Odd-skipped related 1)

CXCL12 overexpression in chick fibroblasts
upregulates connective tissue gene expression

OSR2
(Odd-skipped related 2)

CXCL12 overexpression in chick fibroblasts
upregulates connective tissue gene expression

COL17A1b
(Collagen Type 17 alpha 1b)

Expressed in lateral line, neuromasts.
Knockdown, reduced neuromasts in lateral line
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Primer Design
Set #2: Based off inconclusive data from “Primer Design Set #1,” we decided to modify our
research question. We read through the literature and identified possible genes of interest in
zebrafish that emerge during lateral line development.

Primer Design Set #2
Gene

Description

Control

B-actin 1: Beta-actin 1

reference gene control

Control

GAPDH: Glyceraldehyde 3phosphate dehydrogenase

reference gene control

Ligands

CXCL14
(Chemokine ligand 14 a)

Predicted to have chemokine activity, involvement in
cell chemotaxis and involvement with immune
responses

CXCL12/SDF1
(chemokine ligand 12 a;

Exhibits chemoattractant activity; involved in animal
organ development, nervous system development, and
regulation of cell motility

stromal cell-derived factor 1)

CXCR4
(chemokine receptor 4b)

Receptors

CXCR7B/ackr3b
(chemokine receptor 7b;
atypical chemokine receptor
3b)

Genes
expressed in
neuromasts
and
primordium

Exhibits G protein-coupled chemoattractant receptor
activity; involved in gamete generation, nervous
system development, and regulation of chemotaxis
Exhibits chemokine binding activity; involved in
blood vessel morphogenesis, chemotaxis, and nervous
system development

Snail-1b
(snail family zinc finger 1b)

Predicted to have DNA binding activity and
transcription factor activity; involved in ameboidaltype cell migration, cardiac muscle progenitor cell
migration involved in heart field formation, and
negative regulation of cell-cell adhesion

Cldn-2
(Claudin 2)

Predicted to have structural molecule activity;
predicted to localize to the bicellular tight junction,
integral component of membrane, and plasma
membrane

Epcam
(epithelial cell adhesion
molecule)

Involved in cell-cell adhesion, epiboly involved in
gastrulation with mouth forming second, and liver
development
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1. Go to the NCBI website (National Center for Biotechnology Information, Rockville Pike,
MD, USA) → ncbi.nlm.nih.gov
a. Click on “All databases” and scroll down to “taxonomy”
i. Type in “zebrafish” in the search box, then hit “search”
b. You will be taken to:
Danio rerio  click here
(zebrafish), species, bony fishes
Nucleotide Protein
c. You will be redirected to the “taxonomy browser→ Danio rerio” page
i. To the far right is “Entrez records”
Entrez Records
1. Find “gene 100,231” under
Database Name Direct Links
database name
2. Click on 100,231
Gene
100,231
d. You will be redirected to “gene txid 7955
[organism: no exp]”
i. This tells us it is a zebrafish
e. Type in gene txid 7955 [organism: no exp] AND type in gene of interest here. Hit
search
i. i.e. gene txid 7955 [organism: no exp] AND mpz (Primer design set #1)
ii. i.e. gene txid 7955 [organism: no exp] AND CXCL14 (Primer design set #2)
f. You will be taken to the gene result page
i. If there is more than 1 result (i.e. Scx-a vs scx-b or CXCL14-a vs CXCL14-b),
read through the literature… notably the “materials and methods” section to
see what they picked and why.
g. Note “gene ID” number
h. Scroll down to “genomic regions, transcripts, and products”
i. Hit FASTA
i. You will be taken to the FASTA sequence
i. Note NCBI reference sequence
1. i.e. NC_007113.7 for mpz (Primer design set #1)
2. i.e. NM_131627 for CXCL14a (Primer design set #2)
ii. on the top right corner is
“change region shown”
Change region shown
1. Click on “selected region”
°Whole sequence
*Selected region
2. subtract 500 bp from the “from” value
From: _____ to: ______
and add it to the “to” value.
Update view
3. Hit “update view”
a. This is so you can be a little
Analyze this sequence
upstream and downstream
Run BLAST
iii. On the right is “Analyze this sequence”
Pick Primers
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1. Click “Pick primers”
j. You will be redirected to the “NCBI/Primer-BLAST” homepage
i. Under “PCR template,” is an accession number
1. Record it
a. i.e. For mpz: NC_007113.7 (Primer design set #1)
b. i.e. For CXCL14-a: NM_131627 (Primer design set #2)
ii. Under “Primer parameters,” change PCR product size “Max” from “1000” to
“500”
1. Keep “Min” at “70”
2. Under “Primer pair specificity checking parameters,” ensure that
“Database” is “refseq mRNA” and “organism” is “7955” for Zebrafish
a. Change “Max target size” to “1000”
3. Hit “get primers”
k. After lots of waiting… you will be taken to “NCBI/Primer-BLAST: results”
i. You will be given “Detailed primer reports”
1. Pick the BEST primer choice.
2. Criteria:
a. Length of ~18-24 bases
b. 40-60% GC content
c. Start and end with 1-2 G/C pairs
d. Melting temperature (Tm) of 50-60ºC
e. Primer pairs should have a Tm within 5ºC of each other
f. Primer pairs should not have complementary regions
i. Pick the primers with the least amount of selfcomplementary values
3. Record “forward primer” and “reverse primer” sequences as well as
“fragment size”
2. Repeat the process for all genes of interest so there is a primer set designed for each gene
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Primer Design Set #1: General Information
Gene

Gene ID

Accession #

control

B-actin 1

57934

AF057040

Annealing temp for
PCR amplification
60oC

control

GAPDH

406367

AY818346

60oC

NF-kB

110438511

NW_018394395.1

59°C

SCX-a

100034489

NC_007130.7

60oC

Pmp22-b

678607

NC_007123.7

59°C

Mpz

114417

NC_007113.7

60oC

Mbp-a

326281

NC_007130.7

59°C

OSR1

450059

NC_007124.7

60oC

OSR2

550389

NC_007127.7

59°C

COL17A1b

568794

NC_007124.7

59°C

DT of
CXCL14

DT of
CXCL12

Primer Design Set #1: Sequence Information
Fragment

Gene

Forward Primer

Reverse Primer

control

B-actin

5-TCACCACCACAGCCGAAAG-3

5-AGAGGCAGCGGTTCCCAT-3

98bp

control

GAPDH

5-GTGTAGGCGTGGACTGTGGT-3

5-TGGGAGTCAACCAGGACAAATA-3

121bp

NF-kB

5-GCTCCAGGATGACGTTCAGTA-3

5-CCAGAAAGTCCCGTTGAGGT-3

201 bp

SCX-a

5-TCAGGGAGGGATGAGAGCAG-3

5-TCTGCTCCAGAGAACCGAGA-3

335 bp

Pmp22-b

5-TGGAAACGAGGAGCAGAACC-3

5-AGTGAACCTGAGAGGAGGGT-3

496 bp

Mpz

5-ATTGCGTCCTTAGCCCCATC-3

5-GTGTTTGTATCCTCCAGCCTCT-3

177 bp

Mbp

5-TGTCCGAGTCAAGTTGCTACA-3

5-GCTTTTGGTTGGGCAGTCAG-3

316 bp

OSR1

5-CCTCAATCCCACTGTTCCCC-3

5-AGGCAGGTATGAGCAGGAATG-3

484 bp

OSR2

5-AGTCTTACTGCCCATTCCCG-3

5-AACCGCTCAAACTGTGTGTTTC-3

116 bp

COL17A1b

5-TCACTTTGTCACTAATGCCGAT-3

5-TCACCCTTTTCTCCCCTTGG-3

327 bp

DT
of

size

CXCL14

DT
of
CXCL12
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Primer Design Set #2: General Information
Gene

Gene ID

Accession #

Annealing temp for
PCR amplification

Control

B-actin

57934

AF057040

60°C

Control

GAPDH

406367

AY818346

60°C

CXCL14-a

58151

NM_131627

59°C

CXCL12-a

352944

NM_178307

59°C

CXCR4-b

114447

NC_007120.7

58°C

CXCR7-b

561050

NC_007117.7

59°C

Snail-1b

792194

NM_130989.3

60°C

Cldn-2

562525

NC_007132.7

60°C

Epcam

406454

NC_007124.7

59°C

Ligands

Receptors

Genes
expressed in
neuromasts
and
primordium

Primer Design Set #2: Sequence Information
Gene

Forward Primer

Reverse Primer

Fragment
size

Control

B-actin

5’-TCACCACCACAGCCGAAAG-3’

5-AGAGGCAGCGGTTCCCAT-3

98bp

Control

GAPDH

5’-GTGTAGGCGTGGACTGTGGT-3’

5’-TGGGAGTCAACCAGGACAAATA-3’

121 bp

CXCL14-a

5'-TGCAGATGCACAAGAAAAGG-3’

5'-GGCTTCAAACGTCCTGTGTT-3’

225 bp

CXCL12-a

5'-TTCATGCACCGATTTCCAAC-3’

5'-TGTTGATGGCGTTCTTCAGG-3’

222 bp

CXCR4-b

5'-TACGATGTAAGTTGGCTTGTGA-3’

5'-CTGACTGAGAGGTCGCAAAG-3’

435 bp

CXCR7-b

5'-GAGTTGCCACCACACAAAGG-3’

5'-TGTGCTTAATTGGTCCCTGC-3’

396 bp

Cldn-2

5'-GCGTTTTATTGATTTGCAGGCG-3’

5'-TTGCTGCCCGTTTTATGTGC-3’

353 bp

Snail-1b

5'-CGCTGAAGTTTCGAGGGGAT-3’

5'-CAGTGTTTGCAGTGGAAGGC-3’

485 bp

Epcam

5'-CTGCCCCTGTTTTGGAATGG-3’

5'-GCGTTTGGAAAACGAGACCTT-3’

375 bp

Ligands

Receptors

Genes
expressed in
neuromasts
and
primordium
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Quantitative Real-Time Polymerase Chain Reaction (qPCR)
1. Prepare qPCR reactions
a. Thaw 2x GoTaq qPCR Master Mix (Promega Corporation, Madison, WI, USA),
primer sets, and cDNA on ice
i. Gently vortex and centrifuge 2x qPCR master mix
1. Avoid foaming or extended exposure to light
b. Prepare reaction master mix (MM) for each primer set
i. Protocol was adapted to cut reaction mix from 50 ul to 25 ul
Components

9.5x MM

19x MM
(for duplicates)

Final concentration

2x qPCR Master Mix

12.5 ul

237.5 ul

1x

Forward Primer

0.25 ul

4.75 ul

0.2 uM or 0.05- 0.9 uM

Reverse Primer

0.25 ul

4.75 ul

0.2 uM or 0.05-0.9 uM

Nuclease-free H2O

9.5 ul

180.5 ul

2.5 ul

2.5 ul

cDNA
*add directly to well

To final volume of 22.5 ul
*before cDNA is added

c. Add corresponding cDNA (2.5 ul) to corresponding well in the 96-well plate
(Applied Biosystems, Foster City, CA, USA)
i. This is a modification made to the protocol. Previously, we used 8-strip
qPCR tubes
d. Pipette 22.5 ul of the 9.5x MM into each corresponding well (based off primers)
i. Careful to avoid air bubbles
e. Seal 96-well plate with adhesive cover
i. Ensure there are no bubbles or wrinkles present
f. Spin 96-well plate in the plate centrifuge (Benchmark Scientific Inc., Sayreville,
NJ, USA)
i. Ensure there are no air bubbles or side droplets
2. Run qPCR reactions
a. Bring 96-well plate to the qPCR machine (Applied Biosystems, Foster City, CA,
USA)
i. Load 96-well plate inside the qPCR machine
1. Verify that the loading base is labelled “for 96-well plate use only”
and not “for 8-strip tubes”
a. This will cause the door to become unaligned
32

b. Open the software
i. Login to PC computer by qPCR machine
1. Username: INSTR-USER
2. Password: INSTR-USER
ii. Go to “7500 Software”
1. Use “Guest” (unless you have an account listed)
2. Select “continue without connection”
c. Set up the qPCR reaction
i. Under “Experiment Properties”
1. Select “Design Wizard”
2. Experiment name: NAME IT! (AC date qPCR)
3. Which instrument: 7500 (96 wells)
4. Type of experiment: Quantitation
ii. Under “Methods and Materials”
1. Quantitation Method: Comparative CT (CT)
2. Which reagents: SYBR Green Reagents
3. Which ramp speed: Standard (~2 hours to complete run)
4. Which template: cDNA (complementary DNA)
iii. Under “Targets”
1. How many targets: 1
2. Reporter: SYBR
3. Quencher: None
iv. Under “Samples”
1. How many samples: answer varies*
a. If running a qPCR (using both Actin and GAPDH as
controls) without replicates: 81
i. Troubleshooting: There should be 96 samples. Any
left-over wells should be filled with RNAse-free
H2O and used as blanks
b. If running a qPCR (using just Actin as a control) without
replicates: 72
i. Troubleshooting: There should be 96 samples. Any
left-over wells should be filled with RNAse-free
H2O and used as blanks
c. If running a qPCR with duplicates or triplicate: 96
i. Left-over wells were filled with RNAse-free H2O
and used as blanks.
* Recommendation: only run reactions in duplicates or
triplicates. Load blanks
2. How many replicates: 1
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3.
4.
5.
6.

v.

vi.

vii.
viii.

How many negative controls: 0
Arrange plate by: Columns
Set up biological replicate groups: No biological replicates
When prompted, label the samples according to the order in which
they appear and assign a color
a. This makes it easier when finding samples for the data
analysis
Under “relative quantitation settings”
1. Which sample as reference sample: sample 1
2. Which target as endogenous control: target 1
Under “Run Method"
1. Reaction volume per well: 25 ul
2. Ensure accurate reaction stage set up
a. Holding Stage
i. 95ºC for 10:00 minutes
b. Cycling stages (40)
i. 95ºC for 0:15 seconds
ii. 60ºC for 1:00 minute
c. Melting Curve Stages
i. 95ºC for 0:15 seconds
ii. 60ºC for 1:00 minute
iii. 95ºC for 0:30 seconds
iv. 60ºC for 0:15 seconds
3. See reaction set up then select “Finish designing experiment”
Start run
1. Should be completed after 2 hours and 10 minutes.
Store qPCR reactions in -20 ºC freezer until ready to run gels

qPCR Troubleshooting Guide:
1. Use plate/tube holders. Do not allow tubes or plates to contact the bench, ice, or other
surfaces
a. We switched to 96-well plates since 8-strip tubes advertised as “qPCR tubes” do
not always correspond with the machine
i. This happened, causing the qPCR door to be “unaligned”
2. Do not touch the optical surfaces of plates/tubes (the top or bottom)
a. Do everything in your power to keep plates dust-, dirt- and fingerprint-free
b. If you keep the 96-well plate on ice, the condensation forming can have an impact
on the optical readings. Avoid contact with ice.
3. Be sure to load every well
a. This keeps the machine balanced as well as providing room for “blanks”
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Original qPCR Trial Set-up

Trial Set-up for Duplicates: qPCR Part A- Receptors and Ligands

Trial Set-up for Duplicates: qPCR Part B- Other Transcription Factors

35

Analyzing qPCR Data
1. Export data from qPCR machine onto an excel sheet (Microsoft Corporation, Redmond,
WA, USA)
2. Categorize CT values by gene
a. Create different tabs and label them according to gene name
3. Organize CT values by time point
i.e. Non-injected 24 hours, Sham-injected 24 hours, and Morpholino-injected 24
hours
4. Keep actin control CT values below CT values for genes of interest
5. Perform Mann-Whitney tests to analyze data
a. Calculate CT values based off CT values- See Figure 5
i. Subtract the CT values for gene of interest samples by control samples
i.e. (CXCL12 CT value for Non-Injected 24 hpf) – (Actin CT NonInjected 24 hpf)
ii. Repeat for each trial, time point and injection per gene of interest
iii. Remove trials where control values were not characteristic
i.e. An actin CT value between 25-40

Figure 5: Example for Calculating CT values. Data were arranged by CT values for
genes of interest and endogenous control (Actin). CT values for experimental samples were
subtracted from CT values for control samples. Dots denote which numbers are being
subtracted from each other to calculate CT values. Repeat this process for all injection
incubation periods (non-injections-green, sham injection-red, morpholino injected- blue),
trials and genes of interest. Remove any trials where the control CT values are
uncharacteristically high (between 25-40).
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b. Open data analysis software
i. In this case, GraphPad Prism (GraphPad Software, San Diego, CA, USA)
c. Find “New table and graph”
i. Under “XY,” select “grouped”
1. Grouped tables have two grouping variables, one defined by
columns and the other defined by rows
2. Under “Data table,” select “enter data into a new table”
3. Under “options,” select “enter and plot a single Y value for each
point.”
4. Click on “create”
d. Add calculated CT values for each gene of interest trial to the data sheet
i. On the top of the sheet are groups
1. Assign labels based on injection type and incubation period
i.e. Group A: Non-Injected 24 hpf, Group B: Sham Injected 24 hpf,
Group C: Morpholino Injected 24 hpf
a. Repeat for each time point
ii. Once data is organized, click “Analyze”
e. Log transform data
i. Under “Transform, normalize…” select “transform”
ii. Under “Parameters,” select “Transform Y values using…”
1. In the drop-down box, find and select “Y= Log2(Y)
a. Click “ok”
f. Once data is transformed, click “Analyze”
g. Setting up analysis parameters
i. Under “Column analyses,” select “t tests (and nonparametric tests)”
1. Select two groups at a time (compare injected to non-injected)
ii. Under “Experimental Design,” select “unpaired”
1. Under “assume gaussian distribution?” select “No. Use
nonparametric test.”
iii. Under “Choose test,” select “Mann-Whitney test. Compare ranks”
iv. Hit “ok” to run Mann-Whitney test
h. Record p-values
i. Repeat process for all genes of interest
1. Compare non-injected to sham injected
a. Repeat for each time point
2. Compare non-injected to morpholino injected
a. Repeat for each time point
3. Compare sham injected to morpholino injected
a. Repeat for each time point
6. For graphing data
a. Average CT values for each injection incubation period and for each gene of
interest- See Figure 5
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b. Calculate the standard deviation range for each data set
i. Begin by calculating the standard deviation (st. dev) of the data set
ii. To find the lowest acceptable value, subtract the calculated standard
deviation from the average
iii. To find the highest acceptable value, add the calculated standard deviation
to the average
*This analysis can also be completed with 2-standard deviations
c. Remove any outliers
i. Orange cells denote data points that fall outside the standard deviation
ii. Yellow cells denote data points within decimal points of the accepted
standard deviation range
d. Re-average data that fall within the acceptable standard deviation range

Figure 6: Example for Averaging CT values by trial. Data were organized by gene of interest,
sample type, and trials. All trials were averaged, and standard deviations were calculated.
Standard deviations were added to and subtracted from averages to find standard deviation range.
Any outliers falling outside of the acceptable standard deviation range were excluded and data
were re-averaged. Orange cells denote data points falling outside the acceptable standard
deviation range. Yellow cells denote data points within a few decimal points from the accepted
standard deviation range.

e. Calculate CT values based off accepted CT values- Figure 7
i. Subtract the CT values for gene of interest samples from the CT values for
actin control samples
i.e. (CXCL12 CT value for Non-Injected 24 hpf) – (Actin CT Non-Injected 24 hpf)
ii. Repeat for each injection incubation period per gene of interest
iii. Also repeat this step for every trial
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Figure 7: Example for calculating CT values. Data were organized by average CT values
for genes of interest and the endogenous control (-actin). Averaged CT values for
experimental samples were subtracted from averaged control CT values. Dots denote which
numbers are being subtracted from each other to calculate CT values. Repeat this process for
all injection incubation periods (non-injected- green, sham injected- red, morpholino injectedblue) and genes of interest.

f. Calculate CT values- Figure 8
i. Comparing sham injected embryos to non-injected embryos
1. To find CT values for sham injected embryos, subtract the CT
values of sham injected samples from the CT values for noninjected samples
i.e. (CXCL12 CT value for sham injected 24 hpf) – (CXCL12
CT value for sham injected 24 hpf)
2. Repeat this process for each time point and for every gene of
interest
ii. Comparing morpholino injected embryos to non-injected embryos
1. To find CT values for morpholino injected embryos, subtract the
CT values of morpholino injected samples from the CT values
for non-injected samples
i.e. (CXCL12 CT value for morpholino injected 24 hpf) – (CXCL12
CT value for non-injected 24 hpf)
2. Repeat this process for each time point and for every gene of
interest
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iii. Comparing morpholino injected embryos to sham injected embryos
1. To find CT values for morpholino injected embryos, subtract the
CT values of morpholino injected samples from the CT values
for sham injected samples
i.e. (CXCL12 CT value for morpholino injected 24 hpf) –
(CXCL12 CT value for sham injected 24 hpf)
2. Repeat this process for each time point and for every gene of
interest

Figure 8: Example for Calculating CT values. To calculate the CT values between noninjected and injected samples, non-injected CT values were subtracted from either sham
injected (red) CT values or morpholino injected (blue) CT values. To calculate the CT
values between injections (purple), sham injected CT values were subtracted from morpholino
injected CT values. Highlighted cells denote calculated CT values. Repeat this process for all
genes of interest.
g. Calculate Relative quantification (RQ)- see Figure 10
i. Follow the equation: 2(-CT)
ii. This will give you folding values for each of your samples
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Figure 9: Example for Calculating RQ values. To compare injected samples (sham
injected- red and morpholino injected- blue) to non-injected samples (green), folding values
were calculated using CT values labelled “injected vs non-injected” and used in the
formula: 2-CT. To compare sham injected samples (red) to morpholino injected samples
(blue), folding values were calculated using the CT values labelled “between injections”
and used in the formula: 2-CT. Repeat this process for all genes of interest.

h. Graph folding values using Excel
i. Go to “Insert” and select “Insert Column or Bar graph”
1. When prompted, select 2-D Clustered Column
ii. Go to “Chart Tools” and select “Design”
1. Under “Design,” click on “Select Data”
iii. Go to “Legend Entries Series” and select “Add”
1. When prompted, label “Series Name” as Insert Gene of Interest
Name Here Folding Values
i.e. Series Name: CXCL12 Folding Values
iv. For “Series values,” highlight the calculated folding values
1. Select “ok”
v. Go to “Horizontal (Category) Axis Labels” and select “Edit”
1. For “Axis Label Range,” select “Injections by Time Point” labels
2. Select “ok”
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vi. Go to “Chart Tools” and select “Design”
1. Under “Design,” click on “Add Chart Element”
a. Find “Axes” and select “More Axis Options”
i. Under “Format Axis,” click “Axis Options”
1. Select “Vertical (Value) Axis”
2. Click this button
a. Click on “Axis Options”
i. Select “Logarithmic scale”
ii. Edit Base number to “2”
b. Find “Axis Titles” and select both “Horizontal” and
“Vertical” axis
i. Label the horizontal axis “Injection and Incubation
Period”
ii. Label the vertical axis “Relative Gene Expression”
vii. Repeat this process for:
1. All genes of interest→ Non-injected, sham injected, and
morpholino injected at 24 hpf
2. All genes of interest → Non-injected, sham injected, and
morpholino injected at 36 hpf
3. All genes of interest → Non-injected, sham injected, and
morpholino injected at 48 hpf
4. All genes of interest → sham injected and morpholino injected at
24 hpf
5. All genes of interest → sham injected and morpholino injected at
36 hpf
6. All genes of interest → sham injected and morpholino injected at
48 hpf
i. Graphing folding values using GraphPad PRISM
i. Open GraphPad Prism (GraphPad Software, San Diego, CA, USA)
ii. Find “New table and graph”
1. Under “XY,” select “grouped”
a. Grouped tables have two grouping variables, one defined
by columns and the other defined by rows
b. Under “Data table,” select “enter data into a new table”
c. Under “options,” select “enter and plot a single Y value for
each point”
iii. Add calculated folding values from Excel sheet
1. On the left side of the GraphPad data sheet are numbers
a. Assign labels based on time points- hours post-fertilization
(hpf)
i.e. 1: 24 hpf, 2: 36 hpf, 3: 48 hpf
iv. On the top of the sheet are groups
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1. Assign labels based on injection type
i.e. Group A: Non-Injected, Group B: Sham Injected, Group C:
Morpholino Injected
2. Organized data according to the labels
v. Go to the Navigator Panel under “Graphs”
1. Select “New Graph”
a. Under “Table,” select the Data sheet you want to graph
b. Under “Kind of Graph,” select “Grouped”
c. Find “Summary data” and select
vi. To edit graph
1. Find “Change” and select
a. Under “Left Y axis,” change scale to “Log 2”
i. Click on “ok”
2. Label the X-axis and Y-axis
3. Title graph
vii. To add error bars and averages
1. Select the data table
2. Find “Table format: grouped” and select “enter and plot error
values calculated elsewhere”
a. In the dropdown box, select “Mean, SD, N”
i. Add values to the data table
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How to Make, Run, and Visualize Gels
1. Prepare 1x TAE solution
a. If there isn’t any made, pour 100 mL of 10X TAE and 900 mL dI H2O into a 1L
flask
2. Prepare 1% agarose
a. Mass 0.40 g of agarose (mass on tared weigh paper)
b. Transfer agarose to 125 mL Erlenmeyer flask
c. Add 40 mL of 1x TAE to flask with agarose and mix
d. Microwave for 30 seconds or until solution bubbles
e. Stir solution
f. Microwave solution two more times for another 10 seconds
g. Stir solution and allow flask to cool
3. Prepare gel tray
a. Add 12-well gel comb to designated area in gel tray
b. Lift sides of gel tray and screw tightly
c. Once it is warm to the touch, pour 1% agarose into gel tray
d. Allow gel to set for roughly 15 minutes
4. Prepare gel electrophoresis box (Fotodyne Inc., Hartland, WI, USA)
a. Once 1% agarose gel is set, remove gel comb, unscrew the sides of the gel tray,
push sides down and screw tightly
b. Place gel tray in electrophoresis box
i. Make sure wells are near the black lead end of the gel box
c. Add 1x TAE to gel box, allowing it to cover the gel
5. Load samples
a. When running an RNA gel, load 15 ul of RNA with 2 ul loading dye
b. When running qPCR gels, load 15 ul of qPCR sample with 2 ul loading dye
c. Always load at least one lane with 8 ul of DNA marker with 2 ul loading dye
d. Load samples one at a time through the buffer
i. Be sure not to puncture the gel with pipette tips
* Run one gene of interest (9 samples and marker) per gel
6. Run gel
a. Connect leads (black with black, red with red)
i. Make sure the gel is running towards the red lead
b. Set power supply to ~100 Volts constant current for roughly 30-45 minutes
i. Make sure dye fronts have travelled 2/3rds down the gel
7. Visualize gel
a. Turn on camera and computer
i. Log in- Username: calderoa
Password: BcLU2019
b. Place gel on the UV transilluminator (Fotodyne Inc., Hartland, WI, USA)
c. Place hood over transilluminator and turn on UV light
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d.
e.
f.
g.
h.
i.
j.

Zoom in on gel
Flip switch to “O” position
Take picture and turn off UV light
Flip switch to “I” position
Camera program should open on the computer
Import picture
Print it with the Mitsubishi printer (Mitsubishi Electric, Tokyo, JP)
i. Make sure pixel size is 1280 x 1024
ii. Name file: Nancy AC, date, gel type
k. Log out and turn camera off
l. Discard gel in appropriate gel container
i. Fresh 1% agarose gel container
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Appendix V. Inconclusive data from primer set #1

Figure 10. Effect of Sham and Morpholino injections on Gene Expression in Danio rerio
embryos at 24 and 36 hpf. RT-qPCR examined the mRNA levels of eight zebrafish genes: NFkB, SCX, Pmp22b, mpz, mbp, OSR1, OSR2, and COL17 expressed at 24 and 36 hours postfertilization (hpf) following microinjection with either 1 nl of phenol red (sham) or CXCL14
antisense morpholino in phenol red. Relative gene expression levels were determined using the 2Ct method with β-actin as the reference gene. The statistical significance of the data could not
be determined given low sample size and inconclusive results.
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